Studies of some antiparasitic agents by Renton, Louise Margaret
 
STUDIES OF SOME ANTIPARASITIC AGENTS 
 
Louise Margaret Renton 
 
A Thesis Submitted for the Degree of PhD 
at the 
University of St Andrews 
 
 
  
1997 
Full metadata for this item is available in                                                                           
St Andrews Research Repository 
at: 
http://research-repository.st-andrews.ac.uk/ 
 
 
 
Please use this identifier to cite or link to this item: 
http://hdl.handle.net/10023/13992         
 
 
 
 
This item is protected by original copyright 
 
 
Studies of Some Antiparasitic Agents
a thesis presented by
Louise Margaret Renton
to the
University of St. Andrews
in application for
The Degree of Doctor of Philosophy
i i
St. Andrews September 1996
ProQuest Number: 10166321
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10166321
Published by ProQuest LLO (2017). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
"  ‘4-' J HI I N
..V
■.y
T '
Declaration
I, Louise Margaret Renton, hereby certify that this thesis, which is approximately 
40,000 words in length, has been written by me, that it is the record of work carried 
out by me and that it has not been submitted in any previous application for a higher 
degree.
date \[ signature of candidate
I was admitted as a research student in October 1993 and as a candidate for the degree 
of Ph.D. in September 1994; the higher study for which this is a record was carried out 
in the University of St. Andrews between 1993 and 1996.
date U vnqb signature of candidate
I hereby certify that the candidate has fulfilled the conditions of the Resolution and 
Regulations appropriate for the degree of Ph.D. in the University of St. Andrews and 
that the candidate is qualified to submit this thesis in application for that degree.
date i 1 1 1 ^  b  signature of supervisor
Copyright
In submitting this thesis to the University of St. Andrews, I understand that I am giving 
permission for it to be made available for use in accordance with the regulations of the 
University Libraiy for the time being in force, subject to any copyright vested in the 
work not being affected thereby. I also understand that the title and abstract will be 
published, and that a copy of the work may be made and supplied to any bona fide  
library or research worker.
date \ \  m G  signature of candidate
dedicated with love 
to the memoiy o f my father
m
Acknowledgements
I would like to thank Dr A.R. Butler, my supervisor, for giving me the opportunity to 
carry out this work and for his inspiring and enthusiastic supervision during its 
progress.
I am extremely grateful to Dr M.G. Burdon in the School of Biomedical Science for his 
collaboration, enthusiasm and for allowing me to take-over (and rearrange) his 
laboratory during the antibacterial studies. The immunology in this thesis was carried 
out at the Depaitment of Immunology, The Western Infirmary, Glasgow. I am very 
grateful to Professor F. Y. Liew for his collaboration and to Will Reece for his patience 
in teaching me the methods of parasite cultivation and experimentation.
I am indebted to Professor B.C. Gilbert and Dr A. Whitwood at the University of York 
for their collaboration and help in using ESR tb study the mode of action of qinghaosu, 
also for their sustained interest and continued involvement in this study. I am most 
grateful to Professor Yu-Lin Wu at the University of Shanghai for helpful discussions 
on this subject.
I would like to acknowledge; Dr J.H. Naismith and Dr P. Lightfoot for their time and 
assistance in computer modelling qinghaosu and its derivatives; Dr T.J. Rutherford for 
performing 2D NMR studies on arteether and willingly answering my constant stream 
of questions; Dr G. Kemp for kindly allowing my use of his spectrophotometer and for 
helpful advice regaining fluorescence measurements.
I would like to thank the technical staff in the department and my co-workers in the 
laboratory; Stuart, Garry, Paul, Haitham, Iain, Elaine and Doug for their antics and 
humour over the past thiee years.
I am very grateful for the provision of an EPSRC award and Rollo Trust studentship 
during the period of this resear ch.
IV
Finally, I would like to thank my mother for her unfailing support and encouragement 
throughout my academic career, and Terry who has put up with me being a student all 
these years.
Abbreviations and Symbols
A
ABTS
ATP
B H 4
BSA
CM
CW
DBHG
DBNBS
DMPO
DMSO
DNA
DW
E
EDRF
eV
FCS
GMP
absorbance
[2,2'-azinobis (3-ethyl-2,3-dihydrobenzothiazole-6-sulphonate)]
adenosine triphosphate
(6 R)-teti"ahydi*o-L-biopterin
bovine serum albumin
cytoplasmic membrane
cell wall
dibenzylhydroxyguanidine
3,5-dibromo-4-nitrobenzene sulphonate
5,5-dimethyl-1 -pyiToline N-oxide
dimethyl sulphoxide
deoxyribonucleic acid
diy weight
electr ode potential
endothelium derived relaxing factor
electr on volt
foetal calf serum
guanosine monophosphate
Vi
GSNO
GTP
HCC
I C 5 0
IFN
lUPAC
LPS
NADPH
NMMA
NOS
iNOS
nNOS
QHS
RBS
RNA
S-nitrosoglutathione 
guanosine triphosphate 
hepatocellular' carcinoma 
50% inhibitory concentration 
interferon
International Union of Pure and Applied Chemistry 
rate constant 
lipopolysaccharide 
number of bacteria
reduced nicotinamide adenine dinucleotide phosphate
N-monomethyl arginine
nitric oxide synthase
inducible nitric oxide synthase
neuronal nitric oxide synthase
outer membrane
phosphate buffered saline
peptidoglycan
qinghaosu
Roussin's black salt
ribonucleic acid
vu
s -layer
SD M
S N A P
S N P
Tj-9
T N F
X
Schneiders drosophila medium
S-niti'oso-N-acetylpenicillamine
sodium nitroprusside
Sho-saiko-to
tumour necrosis factor
wavelength
extinction coefficient
vni
Abstract
Each year, between 300 and 500 million people develop malaria. Close to 3 million 
people die as a result. Due to resistance there are now few drugs left which are 
effective against malaria; one is a Chinese herbal remedy called qinghaosu 
(aitemisinin).
A section of this thesis represents an attempt to understand further the mode of action of 
tliis antimalaiial agent. Several mechanisms involving iron have been proposed and the 
main categories reviewed (chapter 3). Techniques including ESR spectrometry, 
fluorescence and absorbance measurements were used to further probe the mode of 
action of qinghaosu. The findings of these studies provide support for a mechanism 
proposed by Wu et a l ,  involving cleavage of the peroxy bridge in qinghaosu with the 
ferrous ion as opposed to antimalaiial activity being due to the generation of high valent 
iron-oxo species.
The ether derivative of qinghaosu, aiteether has been studied using 2D NMR in order to 
provide further insight into the unusual structure of this compound (chapter 4). A 
comparison of the sp^ lactone functionality in qinghaosu with the sp3 ether group in 
arteether was performed. Evidence is presented for different conformations and 
chemical shift values.
The immune system protects the human body from invasion by foreign substances or 
cells. A key part of this immune response comes from cellular components known as 
macrophages. The killing process of macrophages appears to involve nitric oxide. 
However, this natural defence mechanism is not very efficient as the body is 
susceptible to invasion by microbes. The term microbe includes both parasites and 
bacteria.
IX
The toxicity of nitric oxide (NO) and NO donor compounds has been investigated using 
the bacterium E. coli (chapter 5). In addition, studies have been performed using 
par asites. Malarial parasites {Plasmodia) are difficult to culture, therefore Leishmania 
par asites which cause the tropical disease leishmaniasis were used as a model (chapter 
6 ). Evidence is presented for the toxic nature of NO donor compounds towards both 
parasites and bacteria. However, qinghaosu and its derivatives did not prove effective 
against Leishmania mexicana parasites in contrast with their reported antimalaiial 
activity. The conclusions of this study suggest that qinghaosu possesses a toxicity 
mechanism selective for malarial parasites.
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Chapter 1
Tropical Disease and the Immune System
1.1 Malaria
Malaria is one of the major infectious diseases in the world today despite years of effort 
first to eradicate it and when that failed, to reduce its impact on mortality and morbidity. 
The World Health Organisation estimate that there are 300-500 million people infected 
with malaria. 1
M alaria is an infectious disease transmitted by mosquitoes. It is caused by minute 
par asitic protozoa of the genus Plasmodium. Only female mosquitoes suck blood and 
parasites infect a human while a mosquito of the genus Anopheles  is feeding. In 
humans the parasite multiplies in the liver over 7-10 days, causing no symptoms. 
Parasites then burst from the liver cells to invade erythrocytes and multiply again. The 
new parasites invade more erythrocytes. The cycle is repeated, causing fever each time 
parasites break free and invade. If a female Anopheles feeds on this patient, parasites 
multiply in her stomach wall and thousands of new parasites migrate to the salivary 
glands. When the mosquito feeds again she injects saliva containing parasites into 
another human, hence infecting them.^
Humans are host to four species of malaria parasite: Plasm odium  fa lciparum , 
Plasmodium vivax, Plasmodium ovale and Plasmodium malariae. While there are 
considerable m ajor differences between species and their pathogenicity and 
epidemiology as well as subtle but important differences in appearance, development 
and host-paiasite relationships, all four species shaie a common basic life cycle.
The species P. vivax, P. ovale and P. malariae may cause severe illness but are rarely 
fatal. They destroy red blood cells in peripheral capillaiies causing anaemia. These are 
the types of malaria which cause distinctive intermittent fevers. Bouts of fever 
correspond to the reproductive cycle of the par asite. The species P. falciparum  causes 
much more serious and progressive illness. In this case red blood cells become sticky 
and form clumps in the capillaries of the deep organs of the body causing 
microcirculatory arrest. If this happens in the brain, delirium, coma, convulsions and
1
death may result. Cerebral malaria is by far the most serious form of the infection. ^
Each year severe falciparum malaria causes up to 2 million deaths. P. falciparum  
accounts for most of the infections in Africa and for over one third of infections in the 
rest of the world. More than two billion people, nearly 40% of the world's population 
ar e at risk. 3
1,1,1 Disease Control
The strength of malaria is in the enormous reproductive capacity of the par asite and 
mosquito; its weakness is in the long development time before an infected mosquito 
becomes infectious to man.
Vaccination
The malaria parasite has a complex life cycle in the human host and presents a number 
of potential targets for vaccine induced immune attack. Development of effective 
synthetic or recombinant peptide vaccines against malaria has been slower than some 
had anticipated. A complication peculiar to parasites is that protective immune 
responses to these organisms are usually stage-specific: the parasite can escape from a 
protective immune response when it transforms from one stage of its life cycle to the 
next. Therefore, a universally effective malaria vaccine will probably have to include 
antigens from different stages of the par asite life cycle.^
In addition each species has many different strains, and surface proteins vary from one 
to the next, so it is essential to use portions of protein that are common to as many 
strains as possible. Another risk is that the vaccine will allow those rare strains which 
can evade it to become suddenly successful in the population.^
The controversial Colombian malaiia vaccine SPF 6 6  was tested in clinical trials in The 
Gambia and Tanzania. From these studies it was concluded that the effectivness of 
SPF 6 6  was between 8  and 30%. At present this vaccine is undergoing further clinical 
trials and has the potential to become another weapon in the fight against malaria.^
Antimalarial Drugs 
Quinine
In the early 17th centuiy Jesuit missionaiies in South America learned of the medicinal 
value of Cinchona bark to treat and cure fevers. Two centuries later Pelletier and 
Caventou isolated the two main alkaloids contained within the bark; quinine and 
cinchonine. The chemical structure of quinine was elucidated in 1908 and key steps in 
its total synthesis were achieved by Woodward and Doering in 1944. Quinine was the 
first chem otherapeutic com pound and the original antim alarial drug. M ass 
administration of quinine assisted early malaria control projects in Italy and other 
countries.
HH o-c—yr J 
1 N
-C =C H 2
kA/
(1) quinine
Proguanil
A drug produced in the British progranune to find new antimalaiials during the second 
world wai*. It is a biguanidine compound which is converted to the active compound 
cycloguanil by metabolism in the body. This was a very useful drug but its value is 
now limited by resistance.
CHNH
N -C HN - C
N - C CH
NH
(2) proguanil
NH
Cl
CH
(3) cycloguanil
Chloroquine
Unlike the botanical quinine, chloroquine is a synthetically manufactured product. It 
belongs to a class of compounds known as the 4-aminoquinolines, antimalaiials first 
developed in 1934 by the German pharmaceutical company LG. Farben. The ideal 
antimalaiial would have to cure quickly and effectively, it would have to be free of 
untowai'd side effects, it would have to work against all species and strains of malaria 
parasites and it would have to be cheap. Chloroquine came veiy close to that ideal. 
However, during the sixties it was confirmed that chloroquine resistant stiains of P. 
falciparum  had arisen under pressuie of overuse and probably underdosage.^
ÇH 3
H N -C H C H 9 CH 9 CH 0 N'
(4) Chloroquine
Medicinal Plants
Because of the lack of availability of effective and affordable drugs, many of the people 
in disease endemic aieas rely on traditional medical systems for treatment. In most 
cases the ti aditional therapy consists of the administration of plant extracts orally or as 
topical prepai'ations. Scientific evaluation of medicinal plants used in the prepaiation of 
traditional remedies has in the past provided modern medicine with very effective drugs 
for the treatment of paiasitic diseases.
Initially, two approaches are used in the search for new drags from plants;
- the evaluation of ethnomedical information obtained from traditional medical 
practitioners.
- the random screening of plant species against taiget pai asites.
The first approach is considered more productive since it relies on the cumulative 
wisdom of many generations of medical practitioners and any serious toxicity would 
have been detected during the long period of human use of the drug. The random 
screening of plants is employed in highly automated systems with high throughput and 
it is hoped that the very large number of species screened by this method will increase 
the chances of identifying new antipaiasitic agents that are unknown even in traditional 
medicine.^
1.1.2 The Current Situation
The world could easily face a turning point in the next decade wherein multidrug- 
resistant malarial paiasites emerge for which there is no effective drug. The spread of 
multidrug-resistant paiasites which now exist in Southeast Asia, to a high transmission 
area of Africa would be a disaster of immense proportions. Few pharmaceutical 
companies have programmes in antimalaiial drug development and many of these are 
being curtailed or discontinued, one of the reasons being that tropical diseases are not 
given the profile of AIDS or cancer. We need to recognise malaria as an emerging or 
re-emerging disease and take steps now to deal with the threat of untreatable malaria 
within the next decade.^ Due to resistance there are now few drugs left which are 
effective against malaria. One effective drug is a Chinese herbal remedy called 
qinghaosu (artemisinin) and its derivatives. The artemisinins in particular have not 
attracted much funding because traditional herbal medicine cannot be patented and thus 
cannot generate big profits.
At present the French company Rhône-Poulenc Rorer manufactures the ether derivative 
o f qinghaosu called artemether from shrub wormwood extracts. A course of 
artemether, consisting of six 80-milligram doses will cost about £9. This price is 
already subsidised under a deal between Rhone-Poulenc Rorer and the TDR (Tropical 
Diseases Research Programme). However, in Africa the cost could be a real problem. 
Another ether derivative of qinghaosu called arteether is currently being developed by 
the TDR and a Dutch company called Artecef. It is hoped that this drug will be 
registered as soon as 1998 and that its cost will be low.
1.1.3 Qinghaosu
Qinghaosu is the principal component in the antimalaiial effect of the traditional Chinese 
herb Artemisia annua L. or qinghao  . It is effective in vivo against chloroquine- 
resistant strains of Plasmodium falciparum  ^ and is associated with low toxicity. 
Qinghaosu, a representative of the cadinane class of sesquiterpene is now used 
successfully in patients in China with malaria. Derivatives of qinghaosu, such as the 
oil soluble artemether and aiteether and the water soluble sodium aitesunate appear to 
be more potent than qinghaosu itself.
CH
CH
O
(5) qinghaosu
It was to this traditional herbal remedy that Chinese scientists turned in an effort to fight 
the resurgence of malaria. Extraction of the dried leaves of qinghao with petroleum 
ether at low temperatures and chromatography on silica gel w ith subsequent 
recrystallisation gave fine, colourless crystals, named qinghaosu (extract of qinghao) in 
Chinese, but also given the Western name artemisinin. The yield was variable ranging 
from negligible quantities to almost 1 % depending on the aiea from which the plant was 
collected. The formula C 1 5 H 2 2 O5  suggested the compound to be a sesquiterpene and 
reaction with triphenylphosphine to give the phosphine oxide was consistent with the 
presence of a peroxide group. The structure of qinghaosu as well as its absolute 
configuration was determined by X-ray diffraction. The lactone ring has a trans 
configuration. The most unusual feature of the chemical structure is the 1,2,4-trioxane 
ring which may also be viewed as a bridging peroxide group. Qinghaosu is the only 
known 1,2,4-trioxane occurring in nature, although compounds with peroxide bridges 
aie common, particulaiiy in maiine organisms. In extensive clinical trials in China, ^ 0 
qinghaosu showed promise in the treatment of otherwise drug-resistant forms of 
malaiia, notably that caused by P. falciparum.
This discovery has occasioned a considerable amount of research in both China and the 
West into the synthesis, biosynthesis and biological action of qinghaosu.
Nomenclature
Although the Chinese name qinghaosu, meaning extract of green plant, is attractive it is 
frequently misspelt. In qinghaosu the 'q' is pronounced like 'ch' in 'cheat'. The 
system atic name is 3 ,6 ,9-trim ethyl-9,10b-epidioxyperhydropyrano[4,3,2-yk] 
benzoxepin-2-one, but this is hardly convenient for regular use. The name adopted by 
Chemical Abstracts is aitemisinin derived from the plant which is its source. ^  ^
Chemical Reactions of Qinghaosu
The most interesting aspect of the chemistiy of qinghaosu is the stability of the peroxide 
bridge. Indeed, qinghaosu can be recovered unchanged from neutral solvents after 
several days at temperatures up to 150“C. At higher temperatures the peroxide bridge 
is destroyed and (6 ), (7) and (8 ) are formed in low yields,
CH
O
(6)
HO.
O
(7)
(8)
Reduction
Lithium aluminium hydride exhaustive reduction gives the tetrahydroxy compound (9), 
while reaction with hydrogen over palladium results in loss of the peroxide bridge to 
give 11 -deoxyartemisinin (10). Reduction with borohydride leaves the peroxide bridge 
intact, giving the lactol 2-hydroxy-2-deoxoartemisinin (11). This is an important 
intermediate in the synthesis of qinghaosu analogues. ^ 3
CHCH
H a
HqC
CH
(10)
CH
OH
(11)
Antimalarial Activity of Qinghaosu
It is almost certain that the crucial structure in qinghaosu which gives it its antimalaiial 
activity is the peroxide bridge. Other paits of the molecule may be modified without 
loss of antimalarial activity. Removal of one or two of the methyl groups at positions 3 
and 6  (12) leaves a molecule which is still active against P. falciparum.
(12)
10
The lactol (11) obtained by reduction of qinghaosu, although chemically unstable is a 
better antimalarial agent than qinghaosu itself, indicating clearly that the carbonyl group 
is not essential for biological activity.
On the other hand, ll-deoxoartem isininl^ (10) and 2-deoxo-ll-deoxyartem isininl4
(13) are not active against the malarial parasite and neither are the carba-analogues
(14), (15) and ( 1 6 ) . All these compounds lack the peroxide bridge.
CH
CH
(13)
CH CHCH
CH
O
(15) (16)(14)
The converse appears also to be true, many compounds not obviously related to 
qinghaosu but which contain a peroxide group are antimalarial agents. Vennerstrom et 
examined 23 peroxides of diverse chemical structures including di-t-butyl 
peroxide, ascaridole (17) and dihydroascaridole (18). Several were found to be active 
in vitro against P. falciparum  although none were active in vivo. This suggests that the 
remainder of the qinghaosu molecule is responsible for the delivery of the drug to the 
infected erythrocyte in an active form where it can exercise its toxicity to the parasite.
11
CHg CH3
H3C CH3 H3C CH3
(17) (18)
Although the peroxide bridge may be the crucial structure in qinghaosu the rest of the 
molecule has a profound effect on the in vitro and in vivo antimalarial activity of 
qinghaosu and related com pounds. The ether derivative of 2-hydroxy-2- 
deoxoai’temisinin (19) is a better antimalaiial than qinghaosu itself! ^  and is the form of 
qinghaosu which is currently under commercial development. It is generally called 
arteether. Esters (20) are generally as effective as qinghaosu but the corresponding 
acids (21) are much less so. This may be a consequence of their lower solubility in 
lipids. Carbonates (22) are the least effective of this group of compounds. However, 
sodium artelinate (23) is only slightly less effective than qinghaosu in vitro and has the 
advantage of water solubility, and therefore can be administered orally.!^
12
CHCH
T  CH3 
OCH2COOHOCOR
(20) (21)(19)
CHCH
HqC
Y  ^CHg 
O CH nCÆ /COO N a
(23)
Quantum mechanical calculations give excellent correlation between calculation and 
experim ent in cases where the structure has been determ ined by X -ray 
crystallography.^^ Thus it may be possible to use quantum phai'macology to explore as 
yet unsynthesised compounds in the seai'ch for an even better antimalaiial drag.
Mode of Action
The solubility of qinghaosu and its derivatives is a very important factor. For clinical 
applications the drug must be administered in oil as an intramuscular injection. 
However, since the 4th century (when a specific use of qinghao for the treatment of 
malaiia was first recorded) the administration of the active species was in the form of an 
aqueous decoction. Preparation involved soaking a handful of herbs in one litre of 
water, and the patient would drink all of the strained liquor.^l The action of qinghaosu
13
towards the malarial parasite appears to be different from that of chloroquine and this 
may well be why qinghaosu is effective against parasites which have become 
chloroquine resistant.
14
1.2 Leishmaniasis
Malaiia pai'asites aie difficult to culture therefore leishmania pai'asites aie often used in 
paiasitic studies. In effect the disease leishmaniasis is used as a model for malaiia.
Leishmaniasis is a group of diseases with very different clinical manifestations and 
public health consequences, ranging from self-healing disfiguring lesions in a minority 
of cases to severe epidemics with high fatality rates. It is endemic in the tropical 
regions of America, Africa and the Indian sub-continent and in the sub-tropics of 
South-West Asia and the Mediterranean. The disease is caused by species of the 
intiacellular protozoan paiasite belonging to the genus Leishmania.'^'^
Leishmaniasis is transmitted by the bite of female sandflies. These belong to the genus 
Phlebotom us in the 'old world' (Southern Europe, Africa, Middle East, India and 
South-East Asia) and Lutzomyia in the new world (central and South A m e r i c a ) . The 
reservoir of infection is the amastigote form of the parasite. The amastigote is usually 
intracellular and is a roughly spherical structure (2-5 p.m long and 1.5-2.5 |xm broad). 
The sandfly becomes infected by taking up amastigotes during a blood meal, the 
amastigotes being in the blood or skin of the infecting host. The amastigotes are 
liberated from the cells in which they are found (in the stomach of the sandfly) and 
begin to multiply by fission. The amastigote becomes elongated (15-20 \xm long and 
1.5-3 jam broad), this organism  is known as the prom astigote. The mobile 
promastigotes migrate from the gut to the mouth parts of the sandfly and ai*e injected 
during feeding.^^
The leishmaniasis can be classified into four groups:
Cutaneous leishmaniasis, caused by Leishmania major and Leishmania tropica , is the 
most prevalent form of the disease and is characterised by a skin ulcer which heals 
spontaneously leaving an unsightly scai'. Diffuse cutaneous leishmaniasis, caused by 
Leishmania aethiopica and Leishmania mexicana, causes widespread thickening of the
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skin with lesions resembling those of lepromatous leprosy which do not heal 
spontaneously. Mucocutaneous leishmaniasis is caused by Leishmania brazUiensis and 
results in highly disfiguring leprosy-like tissue destruction and swelling. Visceral 
leishmaniasis or kala-azai' is caused by Leishmania donovani or Leishmania chagasi, 
common symptoms include fever, malaise, weight loss and diarrhoea accompanied by 
anaemia, skin darkening and hepatosplenoraegaly. Visceral leishmaniasis is fatal if 
untreated due to the failure of the host to mount an effective, protective immune
response.24
1.2.1 Disease Control
Leishmaniasis, like most diseases due to protozoan infection is lar gely a problem of 
developing countries and therefore offers little commercial incentive for pharmaceutical 
companies to develop cheap but effective antileishmanial drags.
Vaccination
Vaccination may be the best answer to the control of leishmaniasis as individuals who 
have recovered from the disease remain immune to further infection. Therefore, 
vaccination is feasible in principle. However, so far the only immunisation strategy 
used with any success in humans has been restricted to the cutaneous disease.^
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A n tile ishm an ia l D rugs 
A n tim o n ia ls
It is well known that compositions containing antimony and naturally occurring 
compounds have long been used in folk medicine and in cosmetics throughout much of 
the Middle East, though without recognition of the potential toxic effects. In the Middle 
Ages there was a marked enthusiasm for exhibition of antimonials as panaceas. An 
interesting aspect of that lay in the formation of a therapeutic wine by allowing white 
wine to stand in vessels made of antimony, or by placing antimony-containing 
substances in wine for varying times. Eventually not only potassium antimonyl tartrate 
was isolated from such a source, but it was learned from experience that antimonials 
were far from safe remedies. As a result antimonial therapy fell into disuse for several 
centuries. In 1908 it was shown that potassium antimonyl tartrate was successful in 
treating mucocutaneous leishmaniasis. Consequently antimonials were reintroduced 
into therapy and led to a broader base for investigations into antileishmanial a g e n t s .
Most of the antimonial drugs employed in the chemotherapy of paiasitic diseases are 
derivatives of acids of the element. These are usually of complex structure, either as 
derivatives of the hydrated oxides or types having a carbon-antimony bond. Sodium 
antimonyl (V) gluconate (sodium stibogluconate) was the drag of choice for therapy.
Nac
pHjOH ÇH 2 OH
CHOH CHOH
I OH O' ’I , 0 - C H
C H “ ” O— - Sb“  O—  Sb— O CHI ^  \  IC H — O — CH
ffI — Q - C-  O'IIo
9 H 2 0
sodium  antim onyl (V) gluconate - sodium  stibogluconate
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Sodium stibogluconate is among the more potent and well tolerated of antimonial drags 
used in the treatment of leishmaniasis. However, it must be administered daily in 
intramuscular doses for several weeks. Sodium stibogluconate has serious toxic side 
effects including cardiac and/or renal failure and is not very effective against cutaneous
leishmania.^4
P y razo lo [3 j4 '> d ]p y rim id in es
Adenine and hypoxanthine aie indispensable purine bases essential for the growth of 
various parasites such as L. donovani and L. hrazeliensis 25 These par asites being 
incapable of synthesising purines on their own are totally dependent on the host for 
their availability. Hypoxanthine after several enzym ic transform ations by 
hypoxanthine-guanine phosphoribosyl transferase is converted into ATP and 
incorporated into parasite RNA which is vital for its existence. The knowledge of host- 
parasite biochemical differences provide insight into the design and synthesis of 
effective antileishmanial agents.
Pyrazolo[3,4-d]pyrimidines, the isosteres of purines impair the biosynthesis of RNA in 
leishm ania parasites.26 This inhibitory property has led to the design of various 
pyrazolo[3,4-d]pyrim idines w ith a high lipophilic substituent for effective 
antileishmanial activity.
N
N N 
H
N
substitu ted  pyrazolo[3 ,4-d]pyrim idine
18
Experimental drugs such as the pyrazolopyrimidines, allopurinol ribonucleotide the 8 - 
aminoquinoline W R6026 and the steroid synthetase inhibitor itraconazole show 
promise and are currently being evaluated for the treatment of various forms of
leislimaniasis.27
Medicinal Plants
In the case of leishmaniasis more than 20 plant species from as many taxonomic 
families have been shown to contain compounds with significant activity against 
various species of leishmania. The active constituents of the plants have been isolated 
and their activity confirmed. The activity of the antileishmanial plant extracts has been 
attributed to compounds belonging to a diverse chemical group.^
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i) Isoquinolines 
e.g. berberine
OCH
OCH
iii) Q uinones 
e.g. plumbagin
O
CH
OH O
ii) Indole alkaloids 
e.g. hai-maline
iv) Terpenes 
e.g. polyalthialabdane
CH
COOH
1.2.2 Q inghaosu
Qinghaosu and its derivatives have been shown to be effective against Schistosoma  
m ansoni and Clonorchis sinensisP'^ Thus, this group of compounds have broad 
antiparasitic potential. The effectiveness of qinghaosu and its derivatives has been 
investigated against L  major in vitro and in vivo and these compounds were found to 
be active.29
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1 3  The Immune System
The immune system is the body's reaction by which foreign matter both living and non­
living is neutralised or destroyed. The non-specific immune response non-selectively 
protects against foreign substances or cells without having to recognise their specific 
identities: a key part of that response comes from cellular components known as 
macrophages which are found in virtually all organs and tissues, their stmcture vaiying 
somewhat from location to location. For macrophages to respond they have to be 
activated by substances known as cytokines. The role of macrophages is quite 
extensive and includes engulfing foreign matter (phagocytosis) and if necessaiy, killing 
it by injection of cytotoxic substances. Macrophages can also kill invading microbes by 
contact without phagocytosis. It is the killing process which appears to involve nitric 
oxide ( N O ) .
1.3.1 The Physiological Role of Nitric Oxide
In 1980 Furchgott and Zawadski^l demonstrated that the vascular" relaxation induced by 
acetylcholine was dependent on the presence of the endothelium and provided evidence 
that this effect was mediated by a second messenger, later to be known as the EDRF^^ 
(Endothelium Derived Relaxing Factor). The EDRF was identified as nitric oxide.
The mechanism by which vascular relaxation hence vasodilation takes place involves 
the binding of the agent to a receptor on the endothelial cell, which initiates the release 
of Ca^+ ions. Calcium is one of the agents required for the stimulation and action of 
the enzyme NO-synthase which is present in endothelial cells. NO-synthase (NOS) 
converts L-arginine to L-citi-ulline and NO. NO then diffuses from the endothelial cell 
wall into the smooth muscle where it stimulates guanylate cyclase to catalyse the 
conversion of guanosine triphosphate (GTP) into cyclic guanosine monophosphate 
(cGMP). This process triggers a phosphoi"ylation cascade which eventually brings 
about relaxation of the smooth muscle.
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1.3.2 Isoform s of NOS
The family of NOS isoforms generally falls into two categories: (i) a constitutive form, 
regulated by Ca^+ and calmodulin, activated by (6 R)-tetrahydro-L-biopterin (BH4 ) and
(ii) a cytokine-inducible form not known to be regulated post-transcriptionally.33 The 
categories can be divided further according to the tissue NOS is derived from. The 
following NOS isoforms have been cloned and sequenced: constitutive cerebellar^^, 
endothelial and inducible muiine macrophages.35 All NOS isoforms require NADPH 
and O2  as co-substrates. Other known co-factors aie flavin adenine dinucleotide and 
flavin mononucleotide which ai'e believed to form a cycle with NADPH in the reductase 
domain of the enzyme.36 Evidence is consistent with the direct formation and release 
of NO from the enzyme, but this has never been shown quantitatively with any of the 
purified NOS isoforms.
The isoform associated with macrophage function is the inducible form (referred to as 
iNOS); iNOS "knockout mice" have been bred. These animals do not express iNOS 
and provide information on the function of NO in the immune system. iNOS 
"knockout mice" appear to be more susceptible to microbial and paiasitic invasion than 
wild type mice, but only slightly. With other infections the "knockout mice" ai*e no 
more susceptible than the wild type control mice. This implies that NO may be only 
one agent of many involved in the control of infection. Male mice deficient in neuronal
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NOS have been found to exhibit behavioural abnormalities; these animals tend to be 
more aggressive than the control mice. In contrast female nNOS-deficient mice 
exhibited no behavioural abnormalities compaied with the control g r o u p . 3 7
1.3.3 Macrophage cytotoxicity
Once the production of NO from L-aiginine in endothelial cells had been established it 
became clear that a similar* process occurs in activated macrophages and that both nitrite 
and nitrate come from the common precursor, NO. NO production was confirmed 
independently by three g r o u p s , 38 and it now seems certain that in activated 
macrophages there is a process occurring that par allels that taking place in endothelial 
cells. Nature appears to have been economical in using the same enzyme for two 
entirely different tasks but clearly the properties of NO are special enough to make this 
profitable. However, it does pose a problem. If any par t of the body suffers from a 
massive infection there will be much macrophage activity. The NO produced as a 
consequence will have not only substantial cytotoxicity, i.e. it kills the invading cells, 
but will also bring about massive hypotension. This condition is known as septic 
shock and can be fatal. Now that the nature of the species responsible for septic shock 
has been identified much research is being carried out to find a treatment for this 
condition.
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1.3.4 M echanism s o f N itric  O xide Toxicity
As mentioned previously, the cytotoxic effects of nitric oxide are associated with the 
inducible form of the enzyme nitric oxide synthase (iNOS). Once synthesised in the 
cell this enzyme will release lar ge amounts of nitric oxide over a long period of time. 
Under these conditions nitric oxide can exhibit toxicity in various ways:
In h ib itio n  o f DNA Synthesis
DNA represents a major target for NO. Under aerobic conditions NO is converted to a 
nitrosating agent (probably dinitrogen trioxide) which can react with DNA bases or 
intact DNA, to induce base deamination. 39 This reaction alters the structure of DNA 
and can result in genetic changes in the cell because of C-T mutations. NO can also 
initiate DNA strand breaks.'^® This may be due to the formation of peroxynitrous acid 
which can react with double stranded DNA to cause strand breaks.^l NO can also 
inhibit DNA synthesis at concentrations which result in cell toxicity.42
This effect of NO may occur as a result of inhibition of enzymes involved in DNA 
synthesis. A target which has been investigated is ribonucleotide reductase which 
provides deoxyribonucleotides for synthesis of DNA.43 NO donors inhibit this 
enzyme and the P2  subunit of the enzyme contains a tyrosyl free radical which is 
effectively scavenged by NO under aerobic conditions.
NO has been implicated in diabetes.44 NO and oxygen radicals inhibit functions of 
insulin containing cells and may contribute to cell destmction. In pre-diabetic insulitis, 
cytokines secreted from macrophages may inhibit insulin secretion, glucose oxidation, 
DNA synthesis and cause DNA damage.
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F o rm atio n  o f P ero x y n itrite
It has been proposed that NO reacts with siiperoxide (O2  ) in many pathological states 
to form a secondaiy cytotoxic species; the peroxynitrite anion (O N O O  ) 45 Formation 
of peroxynitrite from activated phagocytic cells could mediate nitric oxide dependent 
microbial killing. Peroxynitrite is a potent bactericidal a g e n t , 46 killing E. coli in direct 
proportion to its concentration.
NO + O;- -------^  ONOO"
peroxynitrite
° \  yON - 0
0 . N - 0
O'
CIS tran s
Upon protonation peroxynitrous acid is formed. This is a stiong oxidising agent, it can 
oxidise the bromide ion, the iodide ion, hydi'oxylamine and hydrogen p e r o x i d e . 4 7  The 
decomposition route of peroxynitrous acid at neutral pH is unknown and there is much 
controversy over the mechanism.
At present there aie three proposed mechanisms for the decomposition of peroxynitrous 
acid;
Peroxynitrous acid may undergo homolytic decomposition to form NO 2  and hydroxyl 
radicals ( H 0  ) . 4 8  Beckman et a / . 4 6  have shown that peroxynitrous acid spontaneously 
decomposes to form a potent oxidant with the reactivity of hydroxyl radical without a 
requirement for transition metal catalysis. This is a much favoured explanation as it has 
been shown that peroxynitrous acid can both hydroxylate and nitrate aiomatic amino
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acids such as tyrosine and tryptophan. Also, the polymerisation of methyl acrylate in 
the presence of peroxynitrous acid has been used as additional evidence for the 
formation of free radicals in its decomposition. Although HO- and NO 2  can recombine 
to form nitric acid, this reaction in solution is much slower than most reactions 
involving HO-
Peroxynitrous acid may also undergo heterolytic decomposition to form the nitronium 
cation (NO 2 +) and the hydroxide ion (HO')."^^ This possibility has arisen due to the 
lack of effect of various hydroxyl radical scavengers on the rate of reaction of 
peroxynitrous acid.
The third alternative is the formation of an excited state peroxynitrous acid molecule 
(HOONO*) which is more reactive than the ground state peroxynitrous acid molecule 
but less reactive than the hydroxyl r a d i c a l . A l l  these mechanisms may have a role in 
peroxynitrite mediated toxicity.
ONOO- + H+ ONOOH 
peroxynitrous acid
^  N O /  + HO"ONOOH
HOONO*
peroxynitrous acid decom position
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Inhibition of Mitochondrial Enzymes
This may be another factor in nitric oxide-mediated cytotoxicity. NO has a high affinity 
for iron-containing enzymes and forms paramagnetic mononuclear iron-dithiol- 
dinitrosyl complexes and haem nitrosyl complexes.^^ Therefore, the iron-sulphur and 
haem-containing enzymes in the mitochondrial respiratory chain are potential targets. 
The iron-sulphur centres in complexes I and II of the respiratory chain are inhibited by 
NO.^2 This inhibition of mitochondrial enzymes will cause a drop in ATP levels which 
results in cell death. NO is also able to reversibly de-energise mitochondria. At high 
concentrations, NO will mobilise mitochondrial Ca^+ which disturbs the Ca^+ 
homeostasis and results in cell death.^^
The Toxicity of Reactive Intermediates
Iron catalysed generation of HO from O2 " and hydrogen peroxide (H2 O2 ) results in 
severe and irreversible damage of both mammalian cells and pathogenic microbes. It 
has been shown^"^ that the malarial parasite exerts an oxidant stress on infected red 
blood cells. Lipid peroxidation is used as the indicator of effect of oxidant stress, and 
lipid peroxidation in malaria infected erythrocytes is higher than normal cells. The 
increase in lipid peroxidation in parasitised cells may be due to reactive oxygen species 
generated by the living parasites. One possibility is that some of the oxidants are 
produced secondary to catabolism of host cell haemoglobin.
The effector functions of NO like those of 0 2 " involve iron dependent reactions. 
However the reactivity of NO is more selective and more specific than the reactivity of 
reactive oxygen species. Nitiic oxide synthesised by the inducible nitric oxide synthase 
mobilises cellular iron and inhibits the catalytic activity of iron dependent enzymes.^^ 
This inhibits mitochondrial respiration and causes cytostasis which in most cases is 
reversible.
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The experimental evidence suggests that the pattern of NO induced enzymatic inhibition 
is due to the formation of paramagnetic mononucleai' iron-dithiol-diniti'osyl complexes 
of the general formula Fe(RS)2 (NO ) 2  and paramagnetic nitrosyl haem c o m p l e x e s  
This tai'geting of intiacellular iron explains the specificity as well as the reversibility of 
NO induced metabolic inhibition.
Nitrogen Dioxide: The Toxic Species?
Much research has focused on the toxicity of hydroxyl radicals from the decomposition 
of peroxynitrite, however an equal amount of NO 2  is expected to be formed. N 0 2 - 
contains an unpaired electron making it reactive with many free radicals. It is a highly 
toxic and potent oxidant capable of initiating fatty acid o x i d a t i o i / ^  and nitrosylation of 
ai'omatic amino acids.^^ As oxidation talces place over a period of time the slow action 
of macrophages in destroying bacteria could be attributed to the production of the toxic 
species N 0 2 '.
1.3.5 The Antimicrobial Activity of Nitric Oxide
NO has been demonstrated to exert in vitro microbicidal or microbiostatic activity 
against a rapidly expanding list of helminths, protozoa, yeasts, mycobacteria, bacteria 
and viruses. In a smaller number of cases an in vivo role of NO in the host response to 
infection has been demonstrated in experimental models, providing evidence that it is 
pait of the body's natural defence mechanism.
Antileishmanial Activity
When mouse macrophages aie cultured with inflammatory mediators interferon (IFNy) 
and tumour necrosis factor (TNFa) in the presence of low doses of lipopolysacchaiide
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(LPS) they produce lai’ge amounts of NO measured as nitrite in culture supernatant 
compaied with controls incubated in medium alone.^^ The production of NO correlates 
directly with the antileishmanial activity of the macrophages. Cells activated with IFNy 
and T N F a are very efficient at killing the parasites compared with control cells 
incubated in medium alone. The antileishmanial activity of macrophages is not affected 
by D-NMMA but can be progressively and completely abolished by physiological 
concentrations of L-NMMA (a competitive inhibitor of NO from L-arginine).^! These 
results demonstrate that NO is not only necessary but is sufficient to account for the 
antileishmanial activity in this system.
Antimalarial Activity
The role of nitric oxide has also been demonstrated in malaria i n f e c t i o n . Mice were 
infected with Plasmodium chabaudi chabaudi and developed the infection. NO was 
measured in the plasma as nitiate. When the mice were treated with L-NMMA , NO 
production was completely abolished and the mice were significantly more susceptible 
to infection. These results indicate that NO is at least paitially responsible for the 
resistance against malaria infection.
The W orld H ealth O rganisation have tested the com pounds S-nitroso-N - 
acetylpenicillamine (SNAP), sodium nitroprusside (SNP) and Roussin's Black Salt 
(RBS) in vitro on clones of human malaiia; P. falciparum  D 6  (Sierra Leone clone) and 
W2 (Indochina c l o n e ) . S N A P  is a S-nitrosothiol which decomposes thermally and 
photochemically to form the disulphide and NO.^4 Roussin's Black Salt is an iron 
sulphur cluster nitrosyl which is a potent source of NO. Sodium nitroprusside (SNP) 
can act as a direct electrophilic nitiosating agent. It was found that the drugs had a very 
slight effect on the paiasite with SNP being most active. In comparison to antimalarials 
such as chloroquine and qinghaosu their level of activity was not significant.
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The susceptibility of the human malaria paiasite P. falciparum  to killing by NO and 
related molecules has been investigated. It was found that saturated solutions of NO 
did not inhibit parasite growth, but the oxidation products, nitrite (NO 2 ") and nitrate 
(NO3 -) were toxic to the paiasite in millimolai* concentrations. Pathogens reported to be 
inhibited by cell derived reactive nitrogen intermediates include Leishmania major, 
Shistosoma mansoni and Plasmodium liver stages.
1.3.6 N O; Too M uch of a  G ood Thing?
This certainly seems to be the case with NO production. Small amounts are beneficial 
in intracellular communication, vasodilation and self-defence, while unmodulated 
production becomes toxic. NO overproduction has been implicated in autoimmune 
reactions, such as DNA damage, arthritis and diabetes. Evidence of a role in septic 
shock indicates that overproduction of NO in response to microbial infection can also
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be detrimental.^^
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Chapter 2 
Phytochemistry
2.1 Introduction
Traditional Chinese medicine has been used for thousands of years by a large 
population. It is currently still serving many of the health needs of the Chinese people, 
and still enjoying their confidence. It is practised in China in parallel with modern 
Western medical treatment. In addition to scientific organisations dedicated to modern 
Western medicine, e.g. the Chinese Academy of Medical Sciences and vaiious medical 
schools, a series of parallel institutions have been established in China to promote 
traditional Chinese medicine, such as the Academy of Traditional Cliinese Medicine and 
training institutions. Almost all hospitals in China have a department of traditional 
medicine. Furthermore, a laige number of scientific journals aie dedicated to traditional 
Chinese medicine, covering both experhnental and clinical investigations.
About fifty years ago modern chemical and pharmacological methods were first used to 
investigate traditional medicinal materials in China. With the growth of knowledge in 
chemistry, biochemistry, physiology and pharmaceutics and the progress made in 
scientific instrumentation, there have been an increasing number of scientific reports 
chai acterising the biological activities of the chemical constituents of Chinese medicinal 
materials. 1
The herb Artemisia annua L. (qinghao) has been used in Chinese traditional medicine as 
a treatment for many ills, including fever, haemorrhoids, consumption and malaria. In 
1971 Chinese chemists isolated from the leafy portions of the plant the substance 
responsible for its reputed medicinal action. They named this crystalline compound 
qinghaosu (meaning active principle of qinghao), and it was also given the Western 
name artemisinin. This compound is a sesquiterpene lactone that bears a peroxide 
grouping and unlike most other antimalarials, lacks a nitrogen-containing heterocyclic 
ring system. Qinghaosu has been used extensively and successfully in China against 
both chloroquine-sensitive and chloroquine-resistant stiains of the malarial parasite 
Plasmodium falciparum.'^
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Chinese researchers reported, without giving specific details, that thirty other species of 
Artemisia have been examined but that none yielded extracts with antimalarial activity.^ 
Plant species of the genus Artemisia  that ai*e better known than A. annua include A. 
absinthium, used until the 1920's to prépaie the narcotic and now illegal drug absinthe, 
and A. drancunculus, known as tarragon, used as a spice in cooking.
The earliest mention of Artemisia annua L  occurs in the Prescription/or 52 Kinds o f  
D iseases, so prized by the ancient Chinese that it was recorded on a piece of silk, 
discovered in the Mawangdui Hang dynasty tomb dating from 168 B.C. In this work 
the herb was recommended for treatment of haemorrhoids,^ a translation read;
"Take 5 ton of urine and use it to boil 2 large handfuls of blue Artemisia, 1 gold carp 
the size of a hand, 6  ts'un of finely powdered cinnamon and 2  nodules of dried ginger, 
use to fumigate to kill worms''^
Li Shizhen, the famous herbalist who died 400 yeais ago wrote in his Ben Cao Gang 
Mu (Compendium of Materia Medica) of 1596, that chills and fever of malaria can be 
combated by qinghao prépar ations in the following foiin:
"Take a handful of qinghao, soak in 2 litres of water, strain the liquid and drink".
However, before 1971 the nature of the active principle was unknown and before 1976 
the nature of its chemical stmctuie remained elusive.
In the literature^ it has been reported that the leaves and seeds of A. annua were 
prescribed, the former for children's fevers and the latter for consumption, flatulence, 
dyspepsia, night sweats and to destroy noxious vapours. Extracts of A. annua have 
been used for centuries in China to treat a large number of ailments including the fevers 
associated with malaria. Therefore A, annua may contain many "principles" active 
against these ailments. Conversely, the fever thought to be caused by various diseases 
may have actually been due to malaria and was therefore cured by the active principle, 
qinghaosu.
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2.2 The Chinese Theory of Herbs
An important feature of traditional Chinese medicine is the preference for composite 
prescriptions (combinations of herbs) over single active ingredients. The theory behind 
this practice is that the multiple ingredients should produce synergistic therapeutic 
effects. This ancient concept is not readily compatible with modern pharmacological 
theory since a herbal formulation may contain between twenty and a hundred chemical 
compounds. In addition the amount of each compound may vary with many factors, 
hence quality control is a major issue. However, two recent studies support the 
efficacy of some herbal formulae:
In a controlled double-blind British clinical trial, a formulation of ten herbs proved to be 
effective in treating severe atopic eczema which was resistant to conventional Western 
therapies.^ Although atopic eczema is mild in most cases there is a substantial minority 
in whom the disease is severe and these individuals frequently endure great suffering. 
Topical emollients and corticosteroids are the principal treatments and these are 
generally effective for mild and localised disease. However, they rarely provide 
adequate benefit for those in whom atopic eczema is more widespread or intense. 
Furthermore, the use of topical corticosteroids in children with severe eczema is 
associated with a risk of adverse effects as a result of systemic absorption including 
interference with growth.
It became known that a number of children with atopic eczema were being treated by a 
practitioner of traditional Chinese medicine and that 80% of such patients derived 
substantial benefit from this treatment. Furthermore, routine haematological and 
biochemical screening of these patients demonstrated no evidence of impairment of 
renal, hepatic or bone maiTOw function after 6 months continuous therapy.
In traditional Chinese medicine, atopic eczema is generally treated with medicinal 
plants, particularly in the form of decoctions but also as external applications. 
Decoctions ar e taken by mouth and are generally prepared daily by boiling with water
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for a specified period. Prescriptions include components of several (usually 8-12) 
different plants selected on the basis of an assessment both of the skin and general 
medical state.
In this study the treatment comprised components of plants in widespread medicinal use 
in China. The placebo comprised a mixture of inert plant materials having a similar 
appearance, taste and smell, but with no known benefit in atopic eczema.
The constituents of the treatment formula were acquired from established brokers and 
institutes in the Republic of China, who were able to certify their identity and quality. 
Quality control was strictly enforced and thin-layer chromatography was used to 
"fingerprint" each batch of every constituent. Batches were rejected where this differed 
substantially from that of the reference material.
This study verified the therapeutic effect of an extract prepared from plant materials, 
according to traditional Chinese principles, in a group of children with severe atopic 
eczema. It is possible, although unproven, that several compounds act synergistically 
in this and other similar formulations. In this study none of the plants used were 
known to contain identified compounds beneficial in inflammatory skin disease.
In a randomised, controlled Japanese clinical trial it was shown that an extract of seven 
Chinese herbs helped prevent liver cancer in patients with cirrhosis.^ The term "cancer 
chem oprevention" refers to prevention or prolongation of steps leading to 
carcinogenesis by intervention with drugs before the malignant (invasive) stage of 
carcinogenesis. Hepatocellular carcinoma (HCC) is one of the most common cancers 
in the world with an estimated 500,000-1 million new cases diagnosed yearly. More 
than 80% of patients with HCC have underlying cirrhosis.
This was the first completed, randomised and controlled trial of chemoprevention of 
HCC. It evaluated the preventative effect of Sho-saiko-to (Tj-9) on HCC development. 
Tj-9 is a Chinese herbal medicine which contains crude extracts of seven herbs.
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Concenti*ations of the presumably active components in the Japanese preparation were 
regulated.
Tj-9 was administered to the trial group in a daily oral dose o f 7.5 g, while 
conventional drugs were administered to the control group. Patients were monitored 
for 60 months and the cumulative incidence of HCC and the survival rate in both 
groups was determined.
In conclusion, Tj-9 helped prevent the development of HCC in patients with cirrhosis. 
In addition the higher survival rate of the cirrhotic patients in the trial group could mean 
that Tj-9 had beneficial effects on the clinical course of patients with cirrhosis in 
addition to its inhibitory effect on HCC development. The researchers also noted that it 
was difficult to explain the benefits of Tj-9 as the effect of a single ingredient.
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2,3 Malaria Chemotherapy
How Much Qinghaosu is Present in the Herbal Decoction?
The yield of qinghaosu from A. annua vaiies between 0.01 and 0.5% depending on the 
origin of the herb as well as the season of hai vesting. Concentrations of qinghaosu are 
at a maximum just prior to flowering and are generally about 0.05%, although a figure 
of 0.5% has been recorded for plants growing in Szechuan province in Southern 
China. Therefore, assuming a typical decoction contained 5 g of A. annua, it would 
contain between 0.0005 g and 0.025 g of qinghaosu.^
In clinical trials, significantly higher doses were prescribed; qinghaosu tablets were 
taken orally at a total dosage of 2.5-3.2 g, intramuscular injections of qinghaosu in oil 
suspension or in water suspension were administered at total doses of 0.5-0 . 8  g and
0.8-1.2 g respectively. The ether derivative artemether, being much more oil soluble 
than qinghaosu, was administered as oil solution via intramusculai* injection at a total 
dosage of 0.08-0.22 g. Sodium artesunate, the water soluble ester derivative of 
qinghaosu was administered intramuscularly or by intravenous dripping at a dose of
0.15 g/O  Thus with increasing solubility a smaller dose of the drug was required to 
produce a therapeutic effect.
In comparison with the dose of qinghaosu supplied by the decoction, the doses given in 
clinical trials were significantly higher. This provides further evidence for the benefits 
induced by combinations of herbs (rather than single active ingredients) employed in 
traditional Chinese medicine. It would appear that the multiple ingredients in the 
decoction produce a synergistic therapeutic effect.
It may be that other ingredients in the decoction actually solubilise qinghaosu, thus 
making it more active. This proposal was investigated and the solubility of qinghaosu 
in the presence of herbal extracts determined.
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2.4 A Study of the Bioavailability of Qinghaosu in the
Herbal Decoction
2.4.1 Introduction
According to the literature^, the ancient Chinese remedy qinghao was administered in 
the form of an aqueous decoction. It would appear that the precise combination of 
herbs in the decoction affects the solubility of the active principle making it orally 
effective.
The solubility of qinghaosu in water was compared with the solubility of qinghaosu in 
water containing substances known to be present in qinghao  leaves as well as an 
aqueous decoction of qinghao. The solubility was investigated using high performance 
liquid chr omatography (HPLC).
2.4.2 Extracts Investigated 
Quercetin
0 CH 31irV“‘HgCO^ r
HgCO^
OH Vo OH
The actual constituent in the herb is 6,7,3',4'-tetra-0-m ethyl quercetagetin. This 
compound is not commercially available and quercetin was closest in structure.
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Quercetin differs from this constituent in that “OCH 3  groups are replaced by -OH 
groups.
a-cyclodextrin
OH
OHHO
Cyclohexaamylose; a cyclic oligosacchaiide composed of six D-glucose units.
P-cyclodextrin
OH
OHHO
Cycloheptaamylose; a cyclic oligosacchaiide composed of seven D-glucose units.
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l,8"Cineole (eucalyptol)
2.4.3 Experimental
HPLC analysis was performed using a Perkin Elmer series 410 pump, LC 235 diode 
array detector and GP-lOO graphics printer. Column; Highchrom Lichrosorb RP-18, 
10 pm  (25 cm x 4.6 mm).
Chromatographic Conditions
Mobile phase: 0.01 M NaHP 0 4  - NaH 2 P 0 4  buffer solution [water : methanol (3:1)] 
prepared with HPLC grade solvents. Flow rate; 1.3 cm^ per minute, ambient 
temperature, detection wavelength; 260 nm, detection sensitivity; 0.005 aufs, injection 
volume; 2 0  pi, method for quantitation; pealc mass.
2.5 mM  solutions of extracts were prepared as follows; quercetin (0.085 g), a -  
cyclodextrin (0.24 g), P-cyclodextrin (0.28 g) and cineole (0.038 g) were prepared in 
water (10 cm^). To each solution qinghaosu (0.001 g; 0.4 mmol) was added and left to 
stir overnight. For the control experiment the extracts were prepared as described 
previously but no qinghaosu was added.
A decoction of the herbal remedy was prepaied by boiling the herb (250 cm^) in water 
(500 cm^) and stirring overnight at room temperature. The decoction was filtered and 
qinghaosu (0.001 g; 0.4 nunol) was added to the filtrate (10 cm^). The control for this
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experiment was filtrate only (10 cm^). Each solution was left to stir overnight then 
filtered.
The filtrate from each solution was pre-treated before injection onto the column. ^   ^ To 
each solution (0.4 cm^), 0.2% sodium hydroxide (1.6 cm^) was added, the mixture 
was heated on a water bath at 50“C for 30 minutes then cooled immediately with cold 
water. The solutions were extracted twice with ethyl acetate (2 cm^). Trace amounts of 
ethyl acetate were removed from the aqueous layer under a gentle stream of air. 2.5 M 
acetic acid in ethanol (0.16 cm^) was added and the volume brought up to 2  cm^ with a 
methanol : water mixture; (1:4). All samples were filtered (0.45 pm  filters) before 
injection.
2.4.4 Discussion
Analysis using HPLC showed that water containing the herbal decoction and that 
containing a-cyclodextrin increased the solubility of qinghaosu, while solutions of 
cineole, p-cyclodextrin and quercetin actually reduced qinghaosu solubility (appendix 
1). Further studies confirmed these findings and showed that a-cyclodextrin almost 
doubled the amount of qinghaosu in solution. However, the herbal decoction increased 
qinghaosu solubility only by a factor of approximately 1.5. Therefore, an additional 
factor must control the solubility of the active species, making it orally effective. This 
may be the precise combination of herbs in the decoction which produce a synergistic 
effect.
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Appendices
The effect of herbal extracts on the solubility of qinghaosu in water.
S am p le  P eak  M ass (g)
water /  qhs 0.07
water /  a-cyclodextiin / qhs 0 . 1 1
water / quercetin /  qhs 0.03
water / cineole /  qhs 0.05
water / P-cyclodextrin / qhs 0.05
herbal decoction / qhs 0.18
C o n tro l Sam ple P eak  M ass (g)
water only no peak
water / a-cyclodextrin no peak
water /  quercetin no peak
water /  cineole no peak
water / p-cyclodextrin no peak
herbal decoction 0.09
The corrected peak mass for herbal decoction / qhs is 0.09g
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Chapter 3
The Antimalarial Mechanism of Qinghaosn
3.1 Introduction
Qinghaosu is a potent antimalarial agent, but the basis for its selective toxicity is not 
fully understood. A number of mechanisms which differ in detail have been proposed. 
In this section, a range of mechanisms are reviewed and evaluated using a vaiiety of 
experimental techniques in order to determine the most probable mechanism of action of 
qinghaosu.
It has been proposed (and is generally accepted) that the selectivity of qinghaosu for 
malaiial parasites is due to the fact that malaiial parasites aie rich in haemin, derived 
from  the digestion of host haemoglobin. ^  The human erythrocyte contains the 
equivalent of 20 mM haem which is almost entirely bound to haemoglobin. Malarial 
parasites digest approximately 25% of the host haemoglobin but do not catabolise 
haem. Instead, the accumulated haem is stored in food vacuoles as a polymer called 
haemozoin.
Meshnick et al?- claim that qinghaosu reacts within malaria infected erythrocytes to 
form a product with different solubility and chiomatographic properties from the paient 
drug. In aqueous solution qinghaosu was found to react with haemin to form an adduct 
with identical behaviour. The product of this reaction had a molecular weight of 914 
and did not appeal* to be directly toxic to malarial paiasites. It was suggested that 
activated oxygen may be generated as a by-product of this reaction because, when the 
reaction took place in the presence of erythrocyte membranes, oxidation of protein 
thiols occurs. Evidence in support of the production of free radicals was provided by 
the observation that iron catalyses the generation of free radicals since a spin-trapped 
free radical signal was seen by ESR only when qinghaosu was incubated in the 
presence of iron. Furthermore, when P. falciparum  infected red cells were exposed to 
radiolabelled qinghaosu, a haemin-qinghaosu adduct was isolated, indicating that the 
same reaction occurs in situ?  Direct evidence for the critical role of haemin/haemozoin 
in the mechanism of action of qinghaosu was obtained by Peters et a l?  who
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demonstrated that qinghaosu was at least fifty times less effective against a chloroquine 
resistant strain of paiasite called P. berghei which lacks haemozoin.
In the presence of iron, qinghaosu may undergo Fenton-type reactions^ which can be 
summaiised as follows;
Reduced metal + Oxidant-------- ^  Oxidised metal -f more powerful Oxidant
Fe(II) + H2O2 --------^  Fe(ÏII) + HO + OH'
In this type of reaction involving qinghaosu, hydroxyl radicals or other reactive 
intermediates (e.g. superoxide anion, hydrogen peroxide) may also be produced. They 
may serve as mediators in killing the malarial pai'asite which is known to be susceptible 
to oxidant stress.
These observations aie consistent with a two step mechanism of action of qinghaosu 
which can be summaiised as follows;
Feqinghaosu ------------- ^  R ^  free radical damage (lipid
peroxidation, protein oxidation, alkylation, etc) --------^  cell death
R = mixture of free radicals
The first step is a haem catalysed cleavage of the endoperoxide bridge to form a free 
radical. The second step is free radical damage induced by the drug derived free radical 
or transient intermediate resulting in cell death. Evidence consistent with this 
mechanism includes observations that the endoperoxide bridge is necessary for 
biological activity^ and that free radical scavengers and iron chelators antagonise the 
antimalaiial activity of qinghaosu.^ The necessity of the endoperoxide bridge further
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enhances the hypothesis that qinghaosu exerts its antimalarial activity through the 
oxidant mode.
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3.2 Proposed Reaction Mechanisms
It is generally agreed that the initial step in the mechanism resulting in antimalarial 
activity is a one electron reduction by haem which is produced as the parasites digest 
haemoglobin from the host cell. W hat happens next is not certain. The resultant oxyl 
radical (2) (scheme 1) may be converted into a carbon radical (3) by a 1,5-hydrogen 
transfer. Caibon-centied radicals may be lethal agents, but p-scission of the C- 
OFe(III) bond in radical (3) produces an iron-oxo species and rebound epoxidation 
gives an epoxide, both of which may be responsible for parasite death. However no 
conclusive experimental evidence exists to suggest that this is the case in vivo
Scheme 1 1,5-hydrogeii transfer
Fe(III)Q
(1)
1,5 H shift
Posner et al.^ have presented evidence for Fe(IV)=0 production. The initial step in this 
mechanism is the 1,5 H shift (above), also proposed by Bloodworth et al!^
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Scheme 2 Mechanism of Posner et al.
O
(1)
HO
Q
o
Fe(II)
HO,1,5 H
shift
(3)(2)
p-scission
rebound
epoxidation
by
Fe(IV)=0
On,
HO.HO,
-Fe(II)
Fe(IV)=0
(6)
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A m olecular m echanism  representing these transformations and the evidence 
accumulated for the existence of a high valent iron-oxo intermediate is summarised in 
scheme 2. By means of using an oxygen-18 labelled trioxane and some mechanism 
based synthetic analogues it has been claimed that a cai'bon centred radical formed by an 
oxy radical via an intramolecular 1,5 hydrogen atom shift is important for antimalarial 
activity.
Some experimental evidence supports the intermediacy of a high valent, non-haem, 
iron-oxo species resembling that characteristic of monoxygenase metalloenzymes and 
known to cause oxidative damage to biological macromolecules. It was proposed by 
Posner et a l  that such a high valent iron-oxo species could be formed via homolytic 
oxygen-cai'bon bond scission from a P-ferryloxyethyl radical and that the highly 
electrophilic epoxide (5) (scheme 2) a potent alkylating agent was thus formed.
This proposed mechanism is significant in that it provides mechanistic evidence for the 
intermediacy of high valent iron-oxo species in the moleculai" mechanism of qinghaosu 
action. Furthermore, there is evidence that similar high valent iron-oxo species are 
generated from a dialkyl peroxide. It also probes the possibility that such Fe(IV )=0 
species are formed via homolytic oxygen-cai'bon bond scission from a p-ferryloxyethyl 
radical (3) (scheme 2). This is an explicit proposal of an antimalarial molecular 
mechanism involving highly electrophilic and cytotoxic alkylating epoxides like (5) 
(scheme 2 ).
However, there is a limitation to this mechanism in that C4 stabilisation is more than 
that of a tertiary radical and seems to shunt the iron(II) reduction of that analogue 
towards a different pathway, thereby resulting in low antimalaiial activity.
Furtherm ore, Posner et a l^ ^  have designed and synthesised some structurally 
simplified 1,2,4-trioxanes in order to determine whether they are reduced by ferrous 
iron to form the same kinds of radical intermediates as formed upon qinghaosu 
reduction. The simplified trioxanes were formulated such that an intermediate carbon-
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centred radical could be intercepted before (3-scission of Fe(III)-0- [Fe(IV)=0] either 
by a competing P-scission of a better radical leaving group e.g. X- from a radical 
intermediate (la, scheme 3) or by a competing subsequent 1,5 hydrogen atom shift in a 
radical intermediate (la , scheme 4).
Scheme 3
OMe
(1)
1. Fe(II)
2. 1,5-H 
shift
X —% 
Fe(in)0 o
HO,
OMe
P-scission 
-Fe(III)-0 "
OMe
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Scheme
R'
R
OMe
R'
1. Fe(II)
2. 1,5-H shift Fe(in)0'''o HO',,
OMe
1,5-H
shifty
p-scission
-F e(in )-0
R’
R
HO.
OMe
Such mechanistically competing reactions were expected to interrupt formation of a 
high valent iron-oxo species and thus diminish or undermine the antimalaiial activity of 
analogues. The p-scission pathway is supported by in vitro antimalarial studies.
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Figure
OMe OCH 2 CH 2 OH 
(2)
OMe OCH 2 CH 2 OH 
(1)
The trioxanes (1) and (2) (figure 1) differ by only one atom: silicon vs. tin. Despite 
this small structural difference within a complex organic endoperoxide, C4  p -s ily l 
analogue (1 ) had significant antimalaiial activity in vitro whereas tin analogue (2 ) was 
virtually inactive. These results aie consistent with selective P-scission of MegSn 
(rather than retention of Fe(III)-O ). In order to show that the presence of a tin atom 
does not destroy a trioxane's antimalarial activity, a tin containing dihydroartemisinin 
analogue (3) (figure 2 ) was synthesised and examined.
Figure 2
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It has been proposed that it is haem iron(II) which reduces qinghaosu, with the 
reduction of haemin iron(III) to haem iron(II) being induced by an exogenous, possibly 
thiol-based, electron source. Recent work with either qinghaosu or synthetic 
trioxanes has focused on Fe(II) and commenced with the premise that reductive 
cleavage of the peroxide bridge leads to cai’bon-centred radicals which may be the 
biologically active species. However, haemin iron in oxidation state (III), either in 
haemin itself or in haemozoin may also be a target for qinghaosu interaction. Haynes 
and Vonwillei'l^ evaluated the behaviour of both iron(II) and iron(III) in aqueous media 
which mimicked physiological conditions. Initially a Fenton-type cleavage of the 
perox ide  bridge gave rad icals (1 ) and (2) (schem e 5) w ith  haem in 
[chloroprotoporphyrin IX iron(III)] in aqueous acetonitrile, oxygen loss from the 
peroxide bridge of qinghaosu takes place to give desoxoqinghaosu (Ic), a known 
malaria-inactive metabolite. In addition, radical (2 ) may undergo P-scission to the 
primary carbon-centred radical (2 a) which then forms tetrahydrofuran (2 b).
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Schem e 5 M echanism  of H aynes an d  Von w ilier (haem  iron)
Fe(II)F e(ir
Fe(in)
(1) (2)
Fe(III)Q
HO.
(la)
HO.
O'"OH OH AcO
O
(lb) O
(2b)
HO.
O
(Ic)
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Studies of the behaviour of qinghaosu with non-haem iron(II) and (III) in non-aqueous 
media caused consideration of an alternative viewpoint. In aprotic solvents with 
FeClg/N-acetylcysteine or FeCl2 , qinghaosu undergoes rearrangement to give the 
tetrahydrofuran acetate (3), 4-hydroxydesoxoqinghaosu (4) or the enol lactone (5) 
(scheme 6 ) depending on the catalyst used and the polaiity of the reaction medium.
Scheme 6 Mechanism of Haynes and Vonwiller (non-haem iron)
MeCN
FeCl.
HO
r"? oO iiii^
(4)(3) (5)
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W u et a lM  have p rop osed  the fo llo w in g  m ech an ism  in v o lv in g  the c lea v a g e  o f  the 
peroxy bond in q inghaosu w ith  feiTous iron.
Initially the peroxy bond was cleaved by receiving one electron from Fe(II) to give a 
free radical at 01  and an anion at 0 2  which further reacted with the resulting Fe(III) in 
two different ways;
Scheme 7 Mechanism 1 of Wu et al
.2+ ,3 +
•Fe3 +
Fe 2+
Starting with transfer of an electron from 0 2  to Fe(III), p-scission followed to give a 
carbonyl at C4, leaving a radical at C3 which coupled simultaneously with the 0 1 
radical to afford compound ( 1 ).
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Schem e 8  M echanism  2 o f W u et al.
An alternative mechanism is intramoleculai' hydrogen abstraction, initiating with the 
radical at 01  abstracting the a  -hydrogen from C3. The newly formed C3 radical then 
coupled with 0 2 , after donating an electron from oxygen back to Fe(III), forming the 
epoxide (2) (scheme 8 ). This epoxide could be easily opened by the attack of 6 -OH; 
the attack at C4 resulted in the formation of major product (3) (scheme 8 ). This is 
consistent with the product isolated by Posner et aL 8  Formation of compound (3) 
was confirmed by preparative studies (page 65). However compound (1) could not be 
isolated.
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Alternatively 6 -OH attack at C3 gave an equilibrating mixture of compounds (4), (5) 
and (6 ); scheme 9)
Scheme 9 Mechanism 2a of Wu et al.
G
O
(4)
.HQ
O
OHC
HO.
O
(5)
O
(6)
This mechanism was postulated in order to rationalise experhnental outcomes. Serious 
damage to DNA chains by this cleavage has also been observed. These results provide 
a rational explanation for why qinghaosu affects only the red cell infected by the 
parasite, not the normal red cell [both aie rich in Fe(II)]-the former has a cell nucleus 
whereas the latter does not. The site of DNA damage (the carbohydrate or the base 
moiety) is still under investigation. In all the proposed mechanisms it must be noted 
that the reactions were cairied out in vitro, and therefore may not accuiately mimic what 
occurs in vivo.
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3.3 Experimental
3.3.1 Instrumentation and General Techniques
Routine m elting points were determined with open glass capillaries using an 
Electrothermal lA  9000 series digital melting point appaiatus. Infra-red spectra were 
recorded on a Perkin-Elmer 1330 infra red spectrophotometer. NM R spectra were 
recorded on a Bruker AM 300 spectrometer operating at 300 MHz for ^H and 75.4 
MHz for Chemical shifts (Ô) for ^H and are reported in ppm. Mass spectra 
were recorded on an A.E.I MS-50 spectrometer and fragment ions indicated as m/z 
units.
3.3.2 P re p a ra tio n  of C om pound  (3)
A mixture of qinghaosu (0.56 g; 2 mmol) and ferrous sulphate (0.56 g; 2 mmol) in 
aqueous acetonitrile (1:1, pH 4) was stirred under nitrogen while temperature was 
maintained at 37°C. The reactants dissolved to form a yellow/orange solution and the 
reaction was continued until no stalling material was detectable by TLC. The reaction 
mixture was extracted with ethyl acetate (3 x 20 cm^) and the combined organic layers 
were washed with brine, dried over anhydrous sodium sulphate and evaporated in 
vacuo. The residue was sepaiated by flash chromatography [silica gel, ethyl acetate- 
petroleum ether (1:1) as eluent]. White needles of compound (3), (scheme 8 ) were 
obtained upon recrystallisation from ethanol and diagnostic assignments made; yield 
0.21 g (38%); m.p 149-15EC (lit^^ 150-152“C); (nujol)/cm-l 1745 (C=0), 1270 
(OH); ÔH (300 MHz; CDCI3 ); 5.60 (IH , s, OH), 4.33, 4.56 (IH , dd, CH-OH); 6 c  
(75.4 MHz; CDCI3 ); 171.23 (C =0), 82.84 (C-OH), 68.98 (ÇH 2 -C-OH); m/z 265 
(M+-OH).
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3.4 Studies of the Reaction between Iron and Qinghaosu
3.4.1 E lec tro n  Spin  R esonance (ESR) S tudies
As most proposed mechanisms feature free radicals, ESR was seen as the most suitable 
technique to investigate further the antimalaiial activity of qinghaosu. Spin traps 
(diamagnetic molecules) were used to scavenge reactive free radicals and hence form a 
more stable radical, readily detectable by ESR spectroscopy. The mechanism proposed 
by Wu et was used as a model for the experiments performed.
E x p erim en ta l
ESR spectra were recorded on a Braker ESP 300 spectrometer equipped with an X- 
band klystron and 100 kHz modulation. The hyperfine splittings and g-values were 
determined from the spectiometer field scan, this having been calibrated with the signal 
from Fremy's salt (a^ 1.309 mT, g 2.0055).
ESR experiments involved mixing aqueous acetonitrile (1:1) solutions of Fe(II) 
sulphate (2 mM), qinghaosu (2 mM), and the spin trap [typically 200 mM for DMPO 
(5,5-dim ethyl-1 -pyrroline N-oxide) and 25 mM for DBNBS (3,5-dibrom o-4- 
nitrosobenzene sulphonate)]. All spin traps were purified (recrystallised and frozen) 
prior to use. The resultant solution was placed in a standai'd flat-cell for use with 
aqueous solutions and acquisition of the first spectrum started ca. 1  minute after 
mixing.
R e s u lts
Spin-trapping with DMPO  (1)
MeMe
Me
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Reaction of a radical with DMPO gives a nitroxide which usually has a p-hydrogeii 
splitting characteristic of the initial radical. For example, typically, a caibon-centred 
radical gives a(p_H) 20-22 Gauss whilst an alkoxyl radical gives a^p.^) 15-17 Gauss. A 
mixture of Fe(II), qinghaosu and DMPO (50 mM) gave very weak signals which could 
not be unambiguously interpreted (spectra dmpo_l and dmpo_2). Use of a higher 
concentration of DMPO (200 mM) gave stronger signals (dmpo_3, dmpo_4 and 
dmpo_5) which were inteipreted as follows:
Gauss ag[ Gauss Assignment Symbol (on spectral
15.7
14.72
15.04
22.25
18.24
caibon-centred *
Spin trap degradation product A
C O 2 -  X
(for spectra see appendix 1 )
Spin-trapping with DBNBS (2)
SO3- Na'
+ R
BrBr
N
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DBNBS usually only forms long-lived adducts with carbon-centred radicals, but has 
the advantage that more information on the structure of the initial radical can be 
obtained. In particular, the number of large proton splittings observed gives the 
number of protons at the a-carbon. A mixture of Fe(II) sulphate, qinghaosu and 
DBNBS (2.5 mM) gave very weak signals which could not be unambiguously 
interpreted (dbnbs_l and dbnbs_2). Use of a higher concentration of DBNBS (25 
mM) gave stronger signals (dbnbs_3, dbnbs_4 and dbnbs_5). It is interesting to note 
that the signal intensity grows with time which is indicative of a slow rate of reaction 
between Fe(II) and the peroxide. The signals were inteipreted as follows:
Gauss ajj Gauss Assignment Symbol (on spectral
-13.35
13.45
13.40
13.35 (3H)
11.80 (2H)
6.80 (IH )
•CH3
CH2R
CHRR'
(for spectra see appendix la)
Discussion
The detection of spin adducts of caibon-centred radicals is consistent with degradation 
of qinghaosu by Fe(II) occurring via a radical mechanism. The proposed mechanism 
for oxidation as shown in scheme 1 0  leads to the formation of three radicals; these are 
the methyl radical, a primary radical (3) and a secondary radical (4). Species of this 
type were trapped in the studies using DBNBS as the spin trap.
Reaction in the presence of DMPO lead to the trapping of caibon-centred radicals which 
is again consistent with the proposed mechanism. The nitroxide radical detected, wliich
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lacked a p-splitting, is probably formed as a decay product of some of the initial 
adducts, consistent with an increase in intensity with time. From where the adduct 
which is assigned C02" aiises is uncertain. The lack of observation of an alkoxyl 
radical is not suiprising in view of the rapid intramolecular reairangement expected for 
this species.
It should be noted that if  the radicals formed are free to diffuse away from the Fe(II) 
formed with them {i.e. out of the solvent cage) then protonation of the oxygen anion 
will occur. This diffusion is necessary if the radical is to react with the spin trap. This 
protonation is likely to occur faster than the rearrangements. Oxidation of the 
rearranged radicals to cations by the Fe(III) [and regenerating the Fe(II)] and 
subsequent rearrangement will still give the expected products.
The conclusions of these preliminary ESR experiments are entirely consistent with the 
mechanism proposed by Wu at al.^^ which avoids postulation of a high valence iron- 
oxo intermediate. Evidence was presented for the trapping of primaiy radical (3) and 
secondaiy radical (4) (scheme 10). These radicals are intermediates in the formation of 
compound (1) (scheme 7) and compounds (2) and (3) (scheme 8) respectively. From 
the findings of this study there is no evidence whatsoever to suggest the formation of a 
high valent iron-oxo species such as that proposed in the mechanism of Posner et al.^ 
(scheme 2).
ESR has proven to be a valuable tool in further elucidating the antimalarial mechanism 
of qinghaosu. It will therefore be employed in further studies with qinghaosu and its 
ether derivatives aitemether and arteether, in order to probe further the mode of action 
of these compounds.
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Scheme 10 Radicals Detected from Reaction of Qinghaosu and Iron (II)
+ W
+ H
;CH.
H Q
Major
(3)
Minor
+ Me
OOH \
1,5-H shift
The spin adducts of carbon centred radicals CHg, CH 2 R, -CHRR were detected, and 
ai'e highlighted in the above scheme.
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3.4.2 A Mechanistic Study Involving ABTS
Much evidence has been gathered to support the hypothesis that qinghaosu exerts its 
antimalarial activity through the oxidant mode. The activity of qinghaosu was studied 
in the following experiments.
The reaction of qinghaosu with FeTSPP [tetra (4-sulphonato-phenyl) porphyrin 
Fe(III)] was investigated using an excess of ABTS [2,2'-azinobis (3-ethyl-2,3- 
dihydrobenzothiazole-6 -sulphonate)] as a one electron oxidant trap. If, in the presence 
of Fe(III) qinghaosu acts as oxidising agent, ABTS will be oxidised to the relatively 
stable blue-green cation ABTS+- (^niax. 660 nm, £ 5 5 0  1200 m^ m opl)^^ which is 
detected by spectrophotometiy.
In the presence of FeTSPP the following reactions might be expected;
ABTS --------- ^ ABTS+ oxidation
0 reduction
0 - 3 ^
The radical species formed by reduction of qinghaosu could be responsible for the 
desti'uction of membranes of Plasmodium}^
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Test Compounds - Peroxides and Hydroperoxides
Valions peroxides and hydroperoxides which exhibit antimalarial activity were used to 
probe the mode of action of qinghaosu.
CH 3
H3C -C -O O H ^ ICH 3
t-butyî hydroperoxide
CHc
Ç -O O H
CH 3
cumene hydroperoxide
.0- 0.
H H
hydrogen peroxide
0 _ r o - o - £ ^
CH. CH.
dicumyl peroxide
/O '
CH.I '0 - C -  CH. 
1CH ,
t-butyl peroxobenzoate
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T he A n tim ala ria l A ctivity  o f T est C om pounds
The following compounds have already been tested in vitro on P. falciparum
T est C om pound D - 6  clone W -2 clone
ICsodiM ) IC 5 0  (|xM)
q in g h a o su 0.005 0 . 0 0 2  (most effective)
cum ene h y d ro p ero x id e 62.2 51.0
d icum yl perox ide 62.2 60.0
t-b u ty l p eroxobenzoate 391 2 0 2  (least effective)
E x p erim en ta l
Spectrophotometry was carried out using a Phillips PU 8730 UV/Vis Scanning 
spectrophotometer and a Pye Unicam temperature control unit. Temperature was 
maintained at 30°C.
Test compounds were prepared in acetic acid-acetate buffer (0.1 M) pH 5.2. No 
reaction occurred between (NH^)2 ABTS and the test compound in the absence of 
FeTSPP. Experiments involved FeTSPP (0.009 mmol), (NH4 )2 ABTS (0.009 mmol) 
and test compound (0.06 mmol), and were repeated using EDTA (0.01 mmol) as an 
iron chelator in all contiol samples.
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Results
Peroxides
qinghaosu \  y
dicumyl peroxide >. ABTS - ^  ABTS+
t-butyl peroxobenzoate J
Hydrope roxides
hydrogen peroxide
t-butyl hydroperoxide > ABTS -------------- e- ABTS+-
cumene hydroperoxide
Discussion
This study provides evidence for the oxidation of ABTS to ABTS+- by hydroperoxides 
in the presence of Fe(III). Under these conditions hydrogen peroxide, cumene 
hydroperoxide and t-butyl hydroperoxide instantaneously oxidised ABTS to ABTS+- 
(Xmax. 660 nm). H owever, other peroxides studied (qinghaosu, t-butyl 
peroxobenzoate and dicumyl peroxide) did not oxidise ABTS in the presence of Fe(III). 
From the results obtained there is no evidence to suggest a correlation between the 
antimalaiial activity of the test compounds and their ability to act as oxidising agents. 
Qinghaosu, the most effective antimalarial test compound, was not a good oxidising 
agent in the presence of Fe(III). Although both hydroperoxide and other peroxides are 
antimalarial agents only the former oxidise ABTS to ABTS+-. Therefore, we cannot 
use the ABTS reaction as an indicator of possible antimalaiial activity.
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Due to solubility problems this experiment could not be repeated using a Fe(II) salt. 
However, the reaction of qinghaosu with iron(II)/(III) salts in a vaiiety of solvents was 
followed using spectrophotometry. In all experiments there was little evidence of 
reaction, even after many hours no significant spectral changes occuned.
The results obtained aie consistent with the mechanism proposed by Wu et al. which 
involves Fe(II). It explains why no evidence for the production of ABTS+- in the 
presence of Fe(III) was obtained, and is consistent with no reaction between Fe(III) 
and qinghaosu. Also, in the proposed mechanism, Fe(II) is regenerated and may 
explain the absence of spectral changes.
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3.5 Evidence for the Binding of Qinghaosu to Serum 
Proteins
Introduction
Iron catalyses the activation of qinghaosu to produce free radicals. Evidence for this 
was presented by the ESR study (3.4.1). Free radical reactions appeal' to be critical in 
the mechanism of action of the dmg.
There is an account in the literatures^ which describes the binding of qinghaosu and its 
derivatives to human serum proteins, it is also suggested that this plays a role in the 
antimalarial activity exhibited by these compounds. Qinghaosu, dihydroqinghaosu, 
aitemether and aitesunate bind to human proteins to different degrees, the percentage of 
compound bound to protein has been determined as 64, 43,76 and 59 respectively.
Yang et aL'^^ claim that human serum albumin was alkylated by qinghaosu, but 
provided no conclusive evidence to this effect. The occurrence of reactions between the 
drug and host proteins may have important implications in toxicity and therefore in the 
clinical use of qinghaosu. In order to further investigate this claim, the reaction 
between qinghaosu and bovine seram albumin was studied.
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It is claimed that dihydroqinghaosu-12-O-acetic acid binds to bovine serum albumin to 
form the following product;
i<uii O
BSA
o— CH 2 ” C— N K h-B SA0 “ CHo— C - OH
The reaction of qinghaosu with BSA was studied using fluorescence emission 
spectroscopy. BSA has two tryptophan residues. Each residue is a chromophore 
which exhibits an intrinsic fluorescence. This fluorescence can be used as a probe to 
study the binding of q in g h a o su .E x c ita t io n  of the tryptophan residues in the high 
affinity site occurs at 290 nm. The main pathway for the dissipation of absorbed 
energy is fluorescence at 350 nm.
Tryptophan
C - C - C - O H
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Experimental
Fluorescence measurements were performed using a Perkin Elmer Luminescence 
spectrophotometer, model L3 50B. Data manipulation was carried out using an Elonex 
PC 45011 and graphs printed on a Hewlett Packar d Desk Jet 560C. All solutions were 
prepared in isotonic buffer pH 7.2 and scanned in polymethacrylate cells. Excitation 
wavelength was 290 nm and emission spectra were recorded between 300 and 450 nm 
while temperature was maintained at 25 °C.
E xperim en t 1; T he E ffect of Q inghaosu on the Em ission S pectrum  of 
A lbum in
Albumin (1.5 x 10-7 M) and qinghaosu (0.1 g) were combined. Control solutions; 
albumin (1.5 x 10"7 M) in buffer, qinghaosu (0.1 g) in buffer and buffer only.
E xp erim en t 2: F u r th e r  S tudies of the  B inding of Q inghaosu  to  BSA 
In order to prevent a dilution effect the following solutions were prepared;
Albumin (1.5 x 10"7 M) - solution B
Solution B (50 cm^) containing qinghaosu (0.1 g) - solution A
Control solutions; qinghaosu (0.1 g) in buffer (50 cm^) and buffer only. Test solutions 
were prepared as follows; 8  cm^ A + 2 crn^ B, 6  crn^ A + 4 cm^ B, 5 cm^ A + 5 cm^ 
B, 4 cm^ A + 6  cm^ B, 2 cm^ A + 8  cm^ B.
E xperim en t 3: Is the  Q uan tity  of Q inghaosu Im p o rta n t fo r its B inding 
A bility?
Solutions were prepared as in E xperim ent 2, except solution A which was prepared 
using solution B + qinghaosu (0.0 Ig).
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In all experiments the test solutions and controls were stirred overnight and filtered. 
The emission spectra of all solutions were recorded.
Discussion
In combination with qinghaosu the intensity of the emission spectrum of albumin 
decreased significantly (appendix 2; experiment 1). Upon mixing solutions A and B 
the solution containing most albumin had the most intense spectmm while the solution 
containing most qinghaosu (least albumin) had the least intense spectrum (appendix 2 ; 
experim ent 2). The difference in intensity observed betw een albumin and 
albumin/qinghaosu was not dependent on the amount of qinghaosu used i.e. 0 . 1  or 
0.01 g (appendix 2; experiment 3). However, qinghaosu is not readily soluble in 
aqueous medium and the findings of experiment 3 indicate that a certain amount of 
qinghaosu (less than or equal to 0 . 0 1  g) has gone into solution.
The reduction in intensity of the emission spectrum of albumin observed upon addition 
of qinghaosu is consistent with it binding to bovine serum albumin. These results 
indicate only this and provide no evidence of alkylation as proposed by Yang et a l  20 
However, the binding of qinghaosu to proteins has implications for our understanding 
of the drug's pharmacology. Qinghaosu is known to be selective for malarial parasites 
containing iron. It is proposed that the binding of qinghaosu to the parasite protein may 
have a role in the selective toxicity observed Le. qinghaosu binds strongly to malarial 
parasites containing iron and much less strongly to parasites which lack iron. In effect 
the selective toxicity of qinghaosu may be due to the presence of iron and we find no 
evidence that the situation is complicated by the ability of qinghaosu to effect alkylation 
of human serum albumin.
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Appendices
spin‘'tmpping with DMFO
2 mM Fe(II), 2 mM qinghaosu, 50mM DMPO, MeCN:H20 (1:1) after 1 min
351035003490348034703450  3460
dmpo__l
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dmpo_2 2 mM Fe(H), 2 mM qinghaosu, 50 mM DMPO, MeCN:H20 (1:1) after 15 mins
35103400 35003450 3460 3 470
dmpo_3 2 mM Fe(II), 2 mM qinghaosu, 200 mM DMPO, MeCN:H20 (1:1) after 2 mins
35103480 35003460 3470
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dmpo_4 2 mM Fe(H), 2 mM qinghaosu, 200 mM DMPO, MeCN:H20 (1:1) after 20 mins
35103480 350034703460
dmpo_5 2 mM Fe(H), 2 mM qinghaosu, 200 mM DMPO, MeCN:H20 (1:1) after 40 mins
3480 3490 3500 35103450  3460  3470
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Appemëm la  
m e  with
2 mM Fe(H), 2 mM qinghaosu, 2.5 mM DBNBS, MeCN:H20 (1:1) after 1 min
3490 3500 35103460  3470  3480
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dbiîbs_2 2 mM Fe(II), 2 mM qinghaosu, 25 mM DBNBS, MeCN:H20 (1:1) after 1 min
349034803450  3460 3470
dbnbs_3 2 mM Fe(II), 2 mM qinghaosu, 25 mM DBNBS, MeCN:H?0 (1:1) after 4 mins
/
3480 3490 35003440  3450  3460  3470
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dbnbs_4 2 mM Fe(H), 2 mM qinghaosu, 25 mM DBNBS, MeCN:H20 (1:1) after 20 mins
3440  3450  3460  3470  3480  34 9 0  3500  3510  3520  3530
dbnbs_5 2 mM Fe(n), 2 mM qinghaosu, 25 mM DBNBS, MeCN:H2 0  (1:1) after 35 mins
3440  3450  3460  3470  3480  3490  3500  3510  3520
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Fluorescence Studies
Experiment 1
(ex. slit: 1 0 , em. slit: 1 0 )
Intensity (I) at 350 nm 
albumin (1.5 x lO ? M) 110
albumin (1.5 x 10'^ M) + qinghaosu (0.1 g) 70 
qinghaosu (0.1 g) + buffer 15
buffer only 2 0
E x p erim en t 2 
(ex. slit: 5, em. slit: 5)
Intensity (I) at 350 nm 
albumin (1.5 x 10"  ^M) - solution B 590
albumin (1.5 x 10-7 M) + qhs (0.1 g) - solution A 350
qinghaosu (0 . 1  g) + buffer 1 0 0
buffer only 1 0 0
Solutions 8  cm^ A : 2 cm^ B 350
2 cm^ A : 8  cm^ B 500
The solutions prepared between these extremes had very similar intensities.
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Experiment 3
(ex. slit: 1 0 , em. slit: 1 0 )
Intensity (I) at 350 nm 
albumin ( 1.5 x 10’7 M) 105
albumin (1.5 xlO'7 M) + qhs (0.1 g) 70 (see experim en t 1)
albumin (1.5 x 10-7 M) + q^g (o.Ol g) 75
buffer only 15
qinghaosu (0.01 g) + buffer 12
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Experiment 2
600 n
550-
500 -
450
400
350
300INT
250-
200
150-
100 -
50-
-5 4—
300.0 310.0 315.0 320.0 325.0 330.0 335.0 340.0 345.0 350.0 355.0 360.0 365.0 370.0 375.0 380.0 385.0 390.0 400 .
—  buffer only
—  albumin 1.5 x 10'^ M - solution B
—  albumin 1.5 x 10"  ^M + qinghaosu (0.1 g) - solution A  
qinghoasu (0.1 g) + buffer
INT
600
5 5 0
5 0 0
4 5 0
4 0 0
3 5 0
3 0 0
2 5 0
200
1 5 0
100
310.0 315.0 320.0 325.0 330.0 335.0 340.0 345.0 350.0 355.0 360.0 365.0 370.0 375.0 380.0 385.0 390.0 40(300.0
—  8 cm^ A + 2 cm^ B 
6 cm^ A + 4 cm^ B
—  5 cm^ A + 5 cm^ B 
4 cm^ A + 6 cm^ B
—  2 cm3 A + 8 cm^ B
Experiment 3
1 3 0  n
120 -
110 -
100 -
9 0 -
8 0 -
7 0 -
INT 6 0 -
5 0 -
4 0  -
3 0 -
2 0 -
1 0 -
310.0 315.0 320.0 325.0 330.0 335.0 340.0 345.0 350.0 355.0 360.0 365.0 370.0  375.0 380.0  385.0 390.0
nm
400300.0
buffer only
albumin 1.5 x lOr? M
albumin (1.5 x 10"  ^ M) + qinghaosu (0.01 g) 
qinghaosu (0.01 g) + buffer
Chapter 4
IH and l^C NMR Assignments of Arteether and a Comparison
with those of Qinghaosu
4.1 Introduction
CH
CH
The sti'ucture of qinghaosu (1) was deduced using regular spectroscopic techniques and 
confirmed by X-ray crystallographic studies,^ The correct naming of this compound 
and therefore the correct numbering, is a matter of some complexity. In a recent 
re v ie w ,2 the nam e 3 ,6 ,9 -trim ethy l-9 ,10b -ep id ioxyperhyd ropy rano [4 ,3 ,2 - 
jA:]benzoxepin-2-one was used. This conforms to lUPAC conventions and gives the 
numbering system indicated in (2). Several other numbering systems have been used 
and in most cases they are incorrect. However, in a paper by Cordell et al.^ an 
alternative numbering system was used (3). This is also consistent with lUPAC 
conventions.
CH CH
12 =
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M ost previous NMR studies have used qinghaosu, therefore the ether derivative 
arteether (4) was selected for this study. The aim of which was to provide an 
unambiguous assignment of the NMR of (4). The numbering system shown in (4) is 
used throughout this chapter.
15 m e
;  3"CHg 13 
OCH2CH3
Qinghaosu has been the subject of several NMR spectroscopic studies. Three early 
studies^ produced conflicting assignments for the NMR spectrum, which were 
made even more confusing by different numbering. A later study^ used selective 
heteronuclear decoupling experiments for assigning the carbon signals, but the proton 
data were recorded without spectroscopic assignments of non-equivalent protons. A 
substantial study on qinghaosu by Cordell et al.fi used homonuclear COSY and 2 
dimensional nOe (NOESY) measurements to assign the proton signals.
An interesting aspect of the current study is the compaiison of the spectra of qinghaosu 
and arteether and highlighting the differences in chemical shift which aiise. In addition, 
the effect of the ether group on the conformation of the ring and consequently the whole 
molecule was investigated. All experiments were performed at 500 MHz rather than the 
300 MHz used by Cordell et al., with the expectation that some overlapping multiplets 
may be more fully resolved.
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4.2 Experimental
Spectra were obtained using a Varian Unity + 500 spectrometer, operating at 500.2 
MHz (iH) and 125.7 MHz (^^C). Standard pulse programs were used to generate the 
COSY and DEPT spectra.
4.3 Results and Discussion
The iH  NMR spectrum (appendix; figure 1) showed, as expected, a number of 
multiplets of intensity IH, most of which were sufficiently different in chemical shift to 
perm it location. However, in the region Ô 1.44-1.60 there were a number of 
overlapping multiplets and assignments in this group were obviously impossible. 
Elsewhere in the spectrum there were a number of easily recognised signals where 
assignment was immediate and unambiguous.
In the homonuclear COSY spectrum (appendix; figure 2), some cross peaks were 
missing and justification of the assignments came only after examination of the 
heteronucleai' COSY spectrum (appendix; figure 3). Coupling constants were obtained 
from the J-resolved specti'um (appendix; figure 4).
The only triplet of intensity 3H in the ^H spectium is at 61.20, and this was assigned to 
C-17. In the 2D homonucleai' spectium this correlated with two signals at 63.50 and 
63.90, which we assign to the protons at C-16. Both are quartets of doublets, 
indicating that the protons on the methylene group are non-equivalent and each quartet 
is further split by the proton at C-2.
One of the few simple doublets corresponding to one proton is at 64.90 and to this 
chemical shift the proton at C-2 was assigned. It correlates with a multiplet at 62.60 
(proton at C-3) which in turn conelates with a doublet of 3 protons at 60.95 (C-13) and 
a multiplet at 61.24 (C-3a). By the same process the following multiplets were
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assigned; 61.75 and 61.84 to the a -  and P-protons at C-4 and the signals at 61.50 and 
1.64 to the a -  and P-protons at C-5. The single proton at C - 6  was assigned to a 
multiplet at 61.40, while the methyl group at C-14 was assigned to a doublet at 60.89, 
which was nicely separated from the methyl group at C-13 in an expanded version of 
the low field spectium.
The multiplet of intensity IH  at 61.36 was assigned to the proton at C-6 a; unfortunately 
there aie no cross peaks for this signal. However, it was assumed that the signals for 
a- and P-protons at C-7 aie two overlapping multiplets aiound 61.50. From this signal 
there aie strong cross peaks at 62.05 and 62.38 to which the a -  and P-protons at C - 8  
were assigned. An increased chemical shift is consistent for protons which aie closer 
to the oxygen of the ring.
The J-resolved 2D spectrum showed an interesting splitting pattern for these two 
signals. One is a triplet of doublets and the other a doublet of triplets. If it is assumed 
that geminal coupling makes each a doublet, then trans coupling to one of the protons at 
C - 6  will create two double doublets. W ith overlapping of the two inner lines these 
could appear as two triplets and coupling to the other proton at C - 6  would split each 
line of the triplet into a doublet.
A relayed-COSY experiment was performed, however no additional information was 
obtained from this.
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T able 1
N M R  S pectra l A ssignm ents fo r A rtee th e r
P ro to n C hem ical S h ift 
( 8 )
M u ltip lic ity C oupling  C o n s tan t 
(H z)
2 4.90 d 3
3 2.60 m 3.5
3a 1.24 m -
4 1.75 m -
1.84 m -
5 1.50 m -
1.64 m -
6 1.40 m -
6 a 1.36 m -
7 1.50 m -
1.54 m -
8 2.05 td 15, 4.5
2.38 dt 14 ,4
1 0 a 5.40 s -
13 0.95 d 6 . 2
14 0.89 d 7.5
15 1.44 s -
16 3.50 qd 7.5, 10.5
3.90 qd 7.5, 10.5
17 1 . 2 0 t 7.5
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The 13c NMR spectmm is altogether simpler and the 2D heteronuclear spectrum was 
used to confirm the assignments made in table 1. The signals aie listed in table 2. The 
distinction between quaternary, CH, CH 2  and CH 3  was made by means of the DEPT 
pulse sequence.
T able 2
13 c  N M R A ssignm ents fo r A rtee th e r
C arb o n C hem ical S h ift 
(5)
A ssignm ent
2 1 0 1 CH
3 31.5 CH
3a 53 CH
4 24.5 CH 2
5 35 CH 2
6 45 CH
6 a 37.1 CH
7 25 CH 2
8 36.4 CH 2
9 104 C
1 0 a 8 8 CH
1 0 b 87 C
13 2 0 CH 3
14 13 CH 3
15 26 CH 3
16 64 CH 2
17 16 CH 3
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The signal at 524.5 has a cross peak with a signal at 51.75-1.84 and was therefore 
assigned to C-4, while that at 525.0 correlates with a signal at 51.55 and was assigned 
to C-7. From the cross peak the signal at 531.5 is clearly C-3. Likewise the signal at 
535 is C-5. The signal at 536.4 is correlates with two signals in the Iff NMR spectrum 
at 52.05 and 52.38 and was assigned to C-8 . The signal at 537.1 was assigned to C-6 a 
while that at 545 to C - 6  and 553 to C-3a. The signals at 564 correlate with two signals 
in the NMR spectrum at 53.50 and 53.90 and is therefore C-16. The remaining 
signals at 588 and 5101 were assigned to C-lOa and C-2 respectively.
The chemical shifts for all the protons and carbon atoms in arteether have now been 
unambiguously assigned, although little progress has been made in disentangling the a -  
and p-protons at positions 4,5,7 and 8 . There is an expected large difference in the 
chemical shifts o f the a -  and p-protons at C-8 . This is probably due to the proximity 
of the ring oxygen.
Inspection of a moleculai* model showed that in both methylene groups (C4/5 and C7/8) 
the protons are staggered but the proximity of the ring oxygen does set C - 8  apart from 
the others.
The assignments made were compared with those of Cordell et ah for qinghaosu (table
3). There are a number of differences within the NMR spectrum but nothing of 
great significance. However, within the ^H NMR spectrum our assignments show that 
for C-4, C-5 and C-7 the a -  and P-protons have very similar chemical shifts but 
Cordell et a l  report differences ranging from 50.75 to 50.53. A difference of 50.33 
was found for C - 8  and this was explained previously.
For C - 8  (C-4 in their numbering) Cordell et a l  find the smallest difference between the 
a -  and P-protons. It is likely that the differences between the sets of data is due to the 
fact that in arteether there is an ether group at the same position as a carbonyl group in 
qinghaosu. Therefore there will be changes in the conformation of the ring to which 
these groups are attached and a smaller effect on the conformation of the other rings.
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Evidence for this argument was obtained when potential changes in conformation were 
determined by comparison of the X-ray stmctures of qinghaosu'^ and artemether.^ 
Aitemether was used as a model for arteether as its coordinates were readily available in 
the literature. It contains the -OCH 3  group as opposed to -OCH2 CH3  in arteether.
A rtem ether and qinghaosu have different crystal structures. Artemether has a 
monoclinic crystal structure with space group P2i. Its unit cell parameters are a = 
9.868, b = 18.324 and c = 10.172. In comparison, qinghaosu has an orthorhombic 
crystal structure with space group P2iP2iP2i and unit cell parameters a = 24.077, b = 
9.443 and c = 6.356.
X-ray structures (appendix; figure 5) show that the six membered ring containing the 
carbonyl group in qinghaosu and that containing the ether group in artemether are 
different. This was confirmed by comparison of torsion or conformation angles (table
4). M ost of the measured conformation angles in this ring differ significantly for 
qinghaosu and artemether, while only slight differences were observed for the 
remainder of the molecule. In addition, computer generated molecular models of 
qinghaosu were produced and observed at various angles (appendix; figure 5).
101
Table 3
A C om parison  o f o u r D ata  w ith  those of C ordell et al.
C o rd e ll's C hem ical S h ift O ur C hem ical S h ift
N u m b erin g ( 8 ) N u m b erin g ( 8 )
H C H C
9 3.40 32.8 3 2.60 31.5
8 a 1.75 44.8 3a 1.24 53.0
8 1.87 23.3 4 1.75 24.5
1 . 1 2 1.84
7 1.08 33.4 5 1.50 35.0
1.79 1.64
6 1.42 37.4 6 1.40 26.0
5a 1.37 49.9 6 a 1.36 37.5
5 1.47 24.8 7 1.50 25.0
4 2.05 35.8 8 2.05 36.5
2.43 2.38
3 - 105.2 9 - 104.0
1 2 5.9 93.6 1 0 a 5.4 8 8 . 0
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T able 4
C om parison  of T orsion  (C onform ation) Angles of Q inghaosu  an d
A rtem eth er
q in g h a o su
(1 )  (2 )  (3 ) (4 )  (angle)
0(1) C(2) C(3) C(3a) -30
0(1) C(2) C(3) C(13) -158
0(1) C(lOa) C(lOb) C(3a) 44
0(5) C(2) 0(1) C(lOa) -170
0(5) C(2) C(3) C(3a) 156
0(5) C(2) C(3) C(13) 28
C(2) C (l) C(lOa) C(lOb) -23
C(10b)C(3a) C(3) C(13) 178
C(lOb) C(lOa) 0(1) C(2) -25
C(lOa) 0(1) C(2) C(3) 16
C(lOa) C(lOb) C(3a) C(3) -58
a rte m e th e r
(angle)
51
-177
-55
69
-74
57
55
177
55
-54
51
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At the conclusion of this study there was brought to our attention a paper by Prakash et 
a l  which investigated the 2D spectral assignments of arteether at 400 MHz. The 
majority of assignments made were in agreement with those for qinghaosu, published 
by Cordell et a l ^ Criticism of this paper by Misra et a l  altered assignments to 
further coincide with those for qinghaosu.
However, from the evidence presented in this study the spectral assignments of 
arteether differ from those of qinghaosu. Evidence from spectroscopic studies was 
strengthened by the determination of differences in conformation angles when 
qinghaosu containing C = 0  (sp^) and artemether containing C-OCH 3  (sp3) were 
compared. It has been shown that qinghaosu and artemether have different crystal 
structures, space groups, cell param eters and conformation angles. Therefore 
differences in chemical shift values for qinghaosu and arteether would not be 
unexpected and were in fact observed.
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Chapter 5 
Nitric Oxide and the Immune System
5.1 Introduction
Nitric oxide (NO) and/or NO related compounds are involved in ridding the body of 
unwanted microbes. Therefore it is important to understand the chemistry of these 
compounds. Nitric oxide (NO, nitrogen monoxide) is a colourless, paramagnetic and 
relatively stable gas. The electronic structure of nitric oxide may be considered 
advantageously in the molecular orbital (MO) theory. NO contains one more electron 
than dinitrogen and one less electron than dioxygen and, according to simple MO 
theory, this extra single election occupies an antibonding n  MO. Removal of this 
electron is not too difficult, and indeed the ionisation potential (9.5 eV) is somewhat 
lower than in other diatomic molecules such as CO and N2  (14.5 eV). However, NO is 
not very reactive chemically. As an oxidant the electrode potential of NO is not very 
high (E = +1.18V for NO/N 2 O) and as a reducing agent the electrode potential is not 
very low (E = +0.35V for NO 2  /NO).
NO has a short physiological half-life (between 6  and 30 seconds). However, this 
cannot be due to oxidation by molecular oxygen as reaction with oxygen in aqueous 
solution is much slower than the loss of NO over this time period. However, there is 
strong evidence that the only product obtained in these circumstances is nitrite. It 
appeal's that NO reacts rapidly with NO 2  as it is formed to give N 2 O 3 , the anhydride of 
niti'ous acid as shown in the following reactions
NO + V2 O 2  ------------ ^  NO 2
N O 2  + NO ------------ ^  N 2 O 3
N 2 O 3  + H 2 O  ^  2 HNO 2
114
Whereas in the gas phase the following reactions occur;
2NO + O2  - 
N 2 O4  + H 2 O
2 N O 2 NoO
HNO 2  + HNO 3
The chemistry of the formation and reactivity of nitrosothiols, various nitrosyl 
complexes and its redox related species NO+ (the nitrosonium cation) and NO" (the 
nitroxyl anion) is central to an understanding of the biology of NO 4
NO contains N(II), the nitroxyl ion N(I) and the nitrosonium ion N(III) and each of 
them has a distinctive chemistry unique to itself. NO tends to react rapidly with other 
atoms or molecules that also contain unpaired electrons.
Table 1
Characteristics of NO and its redox forms
species oxidation bond bond N-O stretching unpaired
number order length(A) freq (cm-l) electrons
NO 2+ 2.5 1.15 1840
NO+
NO-
3+
1+
0.95
1.26
2300
1290
0
(diamagnetic)
2
(triplet)
or
0
(singlet)
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The formation of niti'osyl complexes from the reaction of NO with haem proteins, such 
as gu any late cyclase or non-haem iron-sulphur centres is very important in the 
biological chemistry of NO. NO is reactive towaids metal complexes forming a wide 
range of nitrosyl complexes. The reaction of NO with a metal-bearing protein is 
intriguing because it can have either of two opposing effects. In some cases NO can 
activate the protein, for example by triggering the catalytic effects of an enzyme. In 
other instances, however, NO binds to the metal at the protein's active site, preventing 
it from  carrying out its normal function. It is not surprising therefore, that the 
biological chemistry of NO is intimately associated with iron proteins.^
S .1.1 A n tib a c te r ia l A ctiv ity
Viruses, mycobacteria, protozoans, helminths, bacteria and fungi aie among a growing 
list o f microbes that are susceptible to nitric oxide. In order to establish the 
antimicrobial activity of nitric oxide donor compounds the bacterium Escherichia coli 
was selected, one reason being that parasites are difficult to culture. An attraction of 
working with E. coli is that it represents a simplified system. The possibility of 
hai'vesting a laige number of cells in a short time and the advantage offered by a haploid 
organism containing only one chromosome and which can double every 2 0  minutes 
have prompted many investigators to use E. coli.
Growing bacteria, dividing by binaiy fission, exhibit exponential or logarithmic growth 
kinetics until a point of saturation of the culture is reached. During this time the 
increase in the number of bacteria (N) per unit time (t) is proportional to the number of 
bacteria present in the culture.
dN /dt = kN where k is a growth constant
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E. coli can grow on a simple chemical medium in which glucose is the carbon and 
energy source, provided the medium is buffered at a pH near 7 and contains 
magnesium, phosphate and a nitrogen source (ammonium chloride or ammonium 
sulphate). However, strains of E. coli grow more rapidly in a rich broth because it 
supplies many of the compounds which the cell would otherwise have to synthesise. 
E. coli is capable of growing either in the presence of air (aerobically) or in its absence 
(anaerobically). However the growth rate in the absence of air is significantly poorer 
than that achieved with good aeration.^
Cell W alls an d  the  A ssociated S urface L ayers
E. coli is defined as a gram-negative bacterium. The cell wall is responsible for the 
gram staining reaction. The property of being coloured dark violet or not, by the 
staining procedure developed by Gram in 1884 is an important taxonomic feature which 
correlates with many other properties of bacteria. The cell wall may be a bairier to the 
delivery of toxic species to the cell. It is a unique structure which contains murein, also 
known as peptidoglycan. This is composed of a backbone of alternately repeating units 
of the amino sugai’s N-acetylglucosamine and N-acetylmuramic acid. The cell wall is 
very important because it protects the cell against osmotic shock. Without a cell wall 
cells would burst from the osmotic pressure exerted on their cytoplasm membranes as 
these organisms normally exist in dilute aqueous environments.
The cell wall of gram-positive bacteria such as Clostridium  sporogenes has a 
peptidoglycan layer that is relatively thick and comprises approximately 90% of the cell 
wall. This layer acts to fulfil the primary protective function of the wall. The gram- 
negative cell wall also has an outer membrane which is composed of additional 
lipopolysaccharides and proteins not present in gram-positive cell walls. Figure 1 
shows the cell envelopes of gram-positive and gram-negative bacterial cells.
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OM
-PG
CM
(a) (b)
Figure 1
Figure 1 is a schematic diagram of gram-positive (a) and gram-negative (b) cell 
envelopes containing crystalline surface layers. The cytoplasmic membrane (CM) 
consists of phospholipid and membrane-bound proteins; the cell wall (CW) and 
peptidoglycan (PG) layers are composed of peptidoglycan and/or other polymers. The 
outer membrane (OM) is composed of phospholipid membrane proteins, lipoproteins 
and lipopolysaccharides; the crystalline S-layer (S) contains proteins of the outer cell 
wall.
When chemicals attack bacterial cell walls a reaction on the cell wall or membranes can 
alter the permeability of the cell. This can impair the passage of nutrients into the cell, 
as well as allow leakage of cellular constituents from the cell. Damage to the cell wall 
alone does not usually kill the microbial cell. Once inside, the chemical may cause the 
lysis of the cell membrane or precipitate in the cytoplasm of the cell. 2
The mechanism by which nitric oxide exerts antimicrobial activity is not clear. Attack 
by nitric oxide and reactive nitrogen intermediates on vital iron-dependent enzymes has 
been thought to contribute to metabolic dysfunction."^ A decrease in cellular respiration 
and replication has been shown to be associated with high levels of nitric oxide 
produced by cytokine-activated macrophage cells.^
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5.2 Research Programme
The toxicity of a number of NO-containing or producing compounds towards E. coli 
was examined in order to understand better the nature of the non-specific immune 
system. The paiticular topics under scrutiny were;
- the ease of NO release
- the innocence of the NO ligand (is it NO, NO+, NO" ?)
- the baiiier provided by the bacterial cell wall
5.2.1 T est C om pounds
(a) R oussin 's  B lack  S a lt (RBS) Na[Fe4 S3 (NO)7 ]
Roussin's salts (black and red) aie the best known examples of iron-sulphur-nitrosyl 
complexes first described by Roussin in 1858.^ Roussin's black salt [(heptanitrosyl- 
tri-p,3 -thioxotetraferrate (1-)], was prepared by reacting iron(II) sulphate heptahydrate, 
sodium nitrite and sodium sulphide in hot aqueous solution under nitrogen gas. This 
reaction is an example of self assembly.
NO
ONNazS + NaNOz + Fe2S04.7H20 ---- ^  /F e ^ -V S -y ^ -”  Fe(^
ON F ^  NO
ON NO
RBS has essentially C3 V molecular symmetry and contains a flattened Fe4  tetrahedron, 
of which thi'ee faces aie tiiply bridged by sulphur atoms.
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(b) Sodium nitroprusside (SNP) Na2[Fe(CN)5NO]
Sodium nitroprusside (SNP) has been known for more than a hundred years. It was 
synthesised by Playfair in 1848 and is one of the oldest metal nitrosyl complexes. It is 
stable in solution in the absence of light. This complex was of interest because it has a 
very high N-O stretching frequency and is used clinically to lower blood pressure.
Schematic structure of the nitroprusside anion
It has six ligands co-ordinated to a centre iron atom, the iron is present as Fe(II). SNP 
is a nitrosating agent, it reacts with a range of nucleophilic compounds such as azides, 
hydi'oxylamines, amines, carbanions and thiols.^
S-nitrosothiols
The nitrosation of thiols readily forms S-nitrosothiols.^ These compounds decompose 
thermally and photochemically to form the disulphide and NO. The release of NO from 
these compounds is well documented and several have been used clinically to prevent 
platelet aggregation and adhesion to the vessel wall.^
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(c) S-nitroso-N-acetylpenicillamine (SNAP)
This thionitrite from N-acetyl-D ,L-penicillam ine is unusually stable and was 
synthesised by the method of Field et a l
H a C - C -  CHNaNO
(d) S-nitrosoglutathione (GSNO)
This nitrosothiol was synthesised by the method of Hai t^ l
Oii
H O '
NH, Hz
OII
SH
i n
Œ
IIo
o
H 'i  
'•C '"  OHHo
Hr O11a
Hr
N H r
NaNOr
HoO+
SNO 
9 ^ 2  H
,CH k^ ^  N-n. p..
M H;o
oII
ex. OH
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(e) Peroxynitrite
It has been proposed that NO reacts with superoxide (O2 ' ) in many pathological states 
to yield a secondaiy cytotoxic species; the peroxynitrite anion (ONOO")4^ Formation 
of peroxynitrite from activated phagocytic cells could mediate NO-dependent microbial 
killing. Peroxynitrite is a potent bactericidal agent. ^
O 2 " + NO ^  ONO O' + H+ ONOOH
HO + NO 2  N O 3 - + H '
(i) Preparation of l^ethoxyethyi nitrite
This first step in peroxynitrite synthesis involves the reaction of 2-ethoxyethanol with
sodium n i t r i t e .  1 4
C 2 H 5 OC 2 H 4 OH + HONO ^  C2H5OC2H4ONO
(ii) Peroxynitrite formation
This stage involves the reaction of 2-ethoxyethyl nitrite with equimolar hydrogen 
peroxide in basic medium, which ensures that no excess hydrogen peroxide is present 
in the final solution. The yellow colour of this solution is due to the presence of the 
peroxynitrite anion and can be detected by spectrophotometiy.l^
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C 2 H 5 OC 2 H 4 QNQ + HOO' C 2 H 5 OC 2 H 4 OH + ONOO" I
(f) Hydroxyguanidines
These compounds are an interesting target for synthesis since the discovery that the 
biosynthesis of nitric oxide from L-arginine occurs via hydroxyaiginine. 16
HzN^s^NHOH
H 3 N CO 2 '
Success was achieved in the form ation o f dibenzylhydroxyguanidine via 
dibenzylcyanamide by the method of Bailey and De Grazia.1^
(Î) Formation of dibenzylcyanamide
.  CNB,
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(ii) Formation of dibenzylhydroxy guanidine
5.2.2 Antibacterial Studies
i) The toxic effects of a range of NO donor compounds on E. coli were investigated.
ii) Disruption of the bacterial cell wall: experiments were performed whereby the cell 
wall o f the gram-negative bacterium E. coli was disrupted using am picillin and 
lysozyme, thus reducing the hairier preventing access of the toxic species.
iii) It has been proposed that peroxynitrite is a potential bactericidal agent, Once 
protonated peroxynitrite decomposes to form a species with reactivity similar to that of 
a hydroxyl radical plus nitrogen dioxide. The toxic nature of peroxynitrite was 
investigated using L-ascorbic acid (a scavenger of HO ) and its effect on the ability of 
peroxynitrite to kill E. coli was observed.
iv) Electron spin resonance (ESR) spectroscopy was used to detect radical formation 
from peroxynitrite. According to the literature preparation of peroxynitrite 1^  all of the 
hydrogen peroxide used is consumed in the reaction. Therefore, any hydroxyl radicals 
trapped must arise horn the decomposition of peroxynitrite.
v) SNAP decomposition: the decomposition of this S-nitrosothiol by Cu(II) acetate was 
investigated and the effect on antibacterial activity assessed.
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SNO
O H 3 C - C — C H 3
H 3 C " ^  |j 
O
^  q ^2+  ►  NO + disulphide
5.2 ,3  T he N a tu re  o f the  Toxic Species
The antibacterial effects of a number of NO+ containing complexes have been studied 
using the bacterium Clostridium sporogenes. It was discovered that RBS was several 
thousand times more toxic towards C. sporogenes than nitrite. These compounds 
contain the N 0+ moiety and aie good nitiosating agents towaids a variety of substrates 
including amines, carbanions and t h i o l s . T h e i r  inhibitoiy effect may be due to the 
reaction of the coordinated N 0+ with cellulai" taigets rather than to the release of NO. 
This is shown by the fact that NO is less toxic to C. sporogenes than iron-nitrosyl 
complexes. The site of action of the toxic species may be the cell membrane. Payne 
showed by electron microscopy that cells treated with RBS had distorted s h a p e s .
In recent literature^^ it has been reported that RBS generated NO/NO+ and caused cell 
clumping, while SNP generated NO/NO+ and caused cell lysis. It was suggested that 
SNP released NO when illuminated and NO+ in the dark. However NO+ may interact 
with thiols to give nitrosothiols which then release NO. The relative toxicity of SNP 
and RBS under controlled conditions was investigated in order to determine the nature 
of the toxic species.
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5.2.4 Distribution Studies
The theory that the greater toxicity of RBS is due to increased membrane solubility was 
investigated. The organic solvent octanol was used to mimic the cell membrane, and 
solubility was determined by spectrophotometry.
5.2.5 Reactions Monitored Using a NO Sensor
A sensor was used to measure the production of NO in the following circumstances
i) the decomposition of SNAP catalysed by copper (II) ions.
SNAP + Cu^'*'------------ ►  NO + disulphide
ii) the decomposition of SNAP by copper (II) in the presence of hydrogen peroxide.
iii) reaction between cysteine and SNP.
iv) reaction between cysteine and RBS.
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5.3 Experimental 
Instrumentation and General Techniques
Routine melting points were determined with open glass capillaries using an 
Electrothermal lA  9000 series digital melting point apparatus and were uncorrected. 
Infra-red spectra were recorded on a Perkin-Blmer 1330 Infraied Spectrophotometer. 
NMR spectra were obtained on a Varian Gemini spectrometer operating at 200 MHz for 
and 50.3 MHz for or as specified on a Bruker AM 300 operating at 300 MHz 
for iH  and 75.4 MHz for Chemical shifts (ô) for ^H and are reported in 
ppm. Mass spectra were recorded on an A.B.I MS-50 spectrometer and fragment ions 
indicated as m/z units. Spectrophotometry was carried out using a Phillips PU 8730 
UVA^isible scanning spectrophotometer. Quartz cells of 1 cm path length were used 
for measurements. The measurement of nitric oxide was carried out using a World 
Instruments Inc. isolated nitric oxide meter and sensor, model ISO-NO-B. BSR 
studies were performed using a Bruker BR 200D instrument.
Preparation of Roussin's Black Salt (RBS) (a)
Sodium nitrite ( 8  g; 0.02 mol) and sodium sulphide (11.3 g; 0.05 mol) were dissolved 
in water (160 cm^) and the mixture heated to boiling under nitrogen. The reaction 
mixture was removed from the heat source and ferrous sulphate (2 g; 3 mmol) in water 
(80 cm^) was added cai'efully followed by addition of 2 0 % ammonia solution ( 2 0  cm^). 
The reaction mixture was allowed to heat for a further 5 minutes before being filtered 
through a hot hyflo (tieated with silica/water). The filtrate was cooled in ice water and 
filtered. The crude product was recrystallised from water to form shiny black crystals, 
yield 1.5 g (90.4%); v^ax. (THF)/cm-l 1795, 1742, 1726 (NO).
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Preparation of 8-nitroso-N-acetyîpenicillamlne (SNAP) (c)
N-acetyl-D,L-penicillamine (1.91 g; 10 mmol) was dissolved in methanol and 1 M 
hydrochloric acid (40 cm^; 1 : 1 ), cone, sulphuric acid (2 cm^) was added drop wise. 
Sodium nitrite (1.38 g; 20 mmol) was dissolved in water (2 cm^) and added very 
slowly with vigorous magnetic stining. After 30 minutes the precipitate was washed 
with water and air dried, forming deep green crystals with red reflections. The reaction 
mixture and product were protected from light at all stages of the reaction; yield 1.56 g 
(71%); m.p. 152°C (lit» 152-154T); v^ax. THF/cm-l 1720 (NO).
P re p a ra tio n  o f S “iiitro sog lu ta th ione  (GSNO) (d)
To a stirred cold aqueous solution of glutathione (1.53 g; 5 mmol) containing 2 M 
hydrochloric acid (2.5 cm^) was added in one portion sodium nitrite (0.35 g; 5 mmol). 
After 50 minutes at 5°C the resulting pale red precipitate was filtered and washed 
successively with ice-cold water ( 3 x 2  cm^) and absolute ethanol ( 2 x 4  cm^). The 
reaction mixture and product were protected from light at all stages of the reaction; yield 
0.88 g (52%); m.p. 174'C (lit^ 175-176°C); v^ax. (THF)/cm-l 1720 (NO).
P re p a ra tio n  of l-e th o x y e th y i n itr ite  (ei)
Sodium nitrite (95 g; 1.4 mol) and water (375 cm^) were stirred mechanically and 
cooled below 0“C in an ice/salt bath. A mixture of water (25 cm^), conc. sulphuric acid 
(34 cm^) and 2-ethoxyethanol (112.8 g; 1.25 mol) were cooled to 0”C and introduced 
slowly beneath the surface of the nitrite with stirring. The solution was added at such a 
rate that practically no gas evolved and the temperature remained at approx. TC. The 
resulting mixture was allowed to stand in an ice/salt bath until it separated into layers. 
The 2-ethoxyethyl nitrite was dried over magnesium sulphate, then purified by 
distillation; b.p. 112°C (15 mm Hg).
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Preparation of peroxynltrite (eii)
In order to prepare a solution of 0.016 M peroxynltrite, 0.016 M hydrogen peroxide 
(15 cm^), 2 M sodium hydroxide (15 cm^) and water (70 cm^) were combined, 2- 
Ethoxyethyl nitrite (0.2 cm^) was added and after a few minutes the solution turned 
yellow due to the presence of the peroxynltrite anion (ONOO ) which was determined 
by spectrophotometiy, % = 302 nm, £ = 1670 dm^ mol"l cm‘k
Preparation of dibenzylcyanamide (fi)
Cyanogen bromide (4 g; 0.04 mol) in methanol (7 cm^) was added dropwise with 
stirring to a mixture of dibenzylamine (6.78 g; 0.03 mol), anhydrous sodium acetate 
(2.83 g; 0.03 mol) and methanol (3 cm^). This was stirred for 2.5 h at 5°C then at 
ambient temperature for 2 h. The reaction mixture was concentiated under vacuum and 
treated with water ( 8  cm^) then extiacted with dichloromethane ( 3 x 1 0  cm^) washed 
with 2 M hydrochloric acid (10 cm^) and brine (10 cm^) then dried over magnesium 
sulphate. The product was recrystallised from methanol, yielding cream coloured 
needles; 5.4 g (71%); m.p. 42-44"C; V^ax. (Nujol)/cm"l 3420, 3380 (NH), 3060, 
3020, 1562, 1493, 735, 695 (CH), 2196 (ON); 0^  (300 MHz: CDCI3 ); 4.62 (4H, s, 
CH 2 ), 7.30 (lOH, m, Ar); Ôq (75.4 MHz: CDCI3 ); 54.73 (benzyl carbon), 134.61, 
129.23, 129.45, 129.10 (Ar carbons), 139.5 (CN); m/z 222 (M+ ); (Found: C, 81.2; 
H, 6.65; N, 12.6, C 1 5 H 1 4 N 2  requires C, 81.1; H, 6.35; N, 12.6%).
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Preparation of dibenzylhydroxyguanidine (fii)
To a so lution o f hydroxylam ine hydrochloride (0.21 g; 3 m m ol) and 
dibenzylcyanamide (0.44 g; 2 mmol) in purified dimethylformamide (5 cm^) was added 
sodium carbonate (0.59 g; 5.6 mmol) over 10 minutes. The resultant solution was 
heated over a steam bath for 1 h, cooled to 50“C and filtered. The salts were washed 
with warm dimethylformamide and the filtrate and washings combined and reduced 
under vacuum. The residue was added dropwise to ice-water with much scratching and 
stirring. The product was purified by recrystallisation from water yielding white 
needles; 0.42 g (82%); m.p. 120-121°C; v^ax. (nujol)/cm“l 3448 (OH), 3315, 1630 
(NH), 1575,1455, 755, 696 (CH); Sg (200 MHz; CDCI3 ); 7.35 (lOH, m, Ar); 5c 
(50.3 MHz; CDCI3 ); 51.42 (benzyl caiton), 138.3, 127.9, 129.1, 127.7 (Ar carbons), 
157.3 (guanidino); m/z 255 (M +); (Found: C, 70.54; H, 6.50; N, 16.36, C 1 5 H 1 7 N 3 O 
requires C, 70.56; H, 6.71; N, 16.46%).
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5.3.1 Antibacterial Studies
i) Toxicity Studies
In order to investigate the toxicity of test compounds towards bacteria, the bacterium 
Escherichia coli DH5 strain was used. To obtain a standai'd stock culture a loopful of 
E. coli from a slope of pure agai- was transferred to a minimal defined media (10 cm^), 
and the prepaied culture was incubated at 37“C.
The test compounds: SNAP, GSNO and RBS were prepared as saturated solutions in 
phosphate buffered saline (PBS) and their concentrations determ ined by 
spectrophotometry. The stock solutions were further diluted with PBS. DBHG was 
prepared as a stock solution in dimethyl sulphoxide (DMSO) and diluted with PBS. 
Peroxynitrite was prepared immediately prior to each experiment. Cysteine and SNP 
were sufficiently soluble and were diluted to the required concentrations.
Experimental controls: PBS only as controls for SNAP, SNP, GSNO and RBS test 
solutions, PBS/DMSG for DBHG while for the peroxynitrite solution; PBS, sodium 
hydroxide, hydrogen peroxide and water was used as the control. All test solutions 
and controls were filtered (0.45 fxm sterile filters) before use. The solutions were 
exposed to light (200 watt bulb at a distance of 30 cm) or kept in darkness (wrapped in 
aluminium foil).
A growing DH5 culture (10 |il) was added to each of the prepared solutions (1 cn%3) in 
sterile bottles. Each bottle was flamed upon addition of culture in order to prevent 
contamination. An aliquot (100 (xl) from each solution was tiansferred to a sterile agai* 
plate and spread over the surface. The plates were incubated at 37°C for 24 h, after this 
time the colonies were counted.
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ii) Disruption of the Bacteria! Cell Wall
Ampicillin or lysozyme (1 mg) was added to the bacterial culture (10 cm^) and shaken 
at 37°C for 1 h. The culture was added to the test solutions as described in toxicity 
studies (i). Control experiments were run in par allel.
iii) Peroxynitrite Toxicity
L-ascorbic acid (1 mg/100 cm^) was added to the peroxynitrite solution in order to 
scavenge hydroxyl radicals. The culture was added to the test solutions as previously 
described (i).
iv) ESR Studies
Peroxynitrite (1 cm^) and trapping compound 5,5-dimethy 1-1 -pyrroline-N-oxide 
[(DMPO), 0.05 cm^l were combined in a quartz tube and degassed with nitrogen. This 
procedure was carried out at ambient temperature.
v) SNAP Decomposition
Cu(II) acetate (1-2 mg) was added to SNAP (1 cm^) or the control solution - PBS (1 
cm3) - and shalcen before the addition of E. coli.
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5.3,2 Media preparation 
Nutrient Agar (L-Agar)
Oxoid: 28 g of powder per litre of distilled water. Dissolved by boiling and sterilised 
by autoclaving at 1 2 rC  for 15 minutes. The solution was allowed to cool to 45“C then 
dispensed into sterile petri dishes.
Minimal defined media (M9) 
per litre:
disodium hydrogen phosphate (Na2 HP 0 4 ) 6  g
potassium dihydrogen phosphate (KH2 PO 4 ) 3 g
sodium chloride (NaCl) 0.5 g
ammonium chloride 1  g
magnesium sulphate (MgS0 4 . 7 H2 O) ( 1  cm^)
2 0 % glucose solution ( 1 0  cm^)
0 . 0 1  mol dm'3 calcium chloride (C aC y  ( 1 0  cm^)
The prepaied solutions were sterilised by autoclaving at 12 TC  for 15 minutes, allowed 
to cool then combined. To the prepaied media (10 cm^) vitamin B j (1 mg) was added 
and the solution filtered before the addition of E. colt
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5.3.3 Distribution Studies^ ^
Saturated solutions of octanol in water were prepared by shaking octanol (100 cm^) 
with water (25 cm^) or by shaking water (100 cm^) with octanol (25 cm^), SNAP, 
RBS and SNP were dissolved in 5 cm^ of each solution to a final concentration of 1 x 
10-3 rnol d m - 3 (SNAP) and 1 x 10"^ mol d m - 3 (RBS and SNP). Each solution was 
shaken and the spectram of the aqueous and organic layers recorded.
5.3.4 NO Sensor Experiments
(The electi'ode was calibrated for temperature before use)
The test compounds were prepared in phosphate buffer pH 7.4 and purged with 
a r g o n . 23 The vessel was sealed thoroughly to prevent leakage of NO and 
measurements were recorded.
i) SNAP decomposition with Cu(II)
SNAP 9.1 X 10-6 mol dm-3 + Cu(II) 4.76 x 1 0 - 6  mol dm-3
ii) SNAP decomposition with Cu(II): the effect of H2 O2
SNAP 9.1 X 10-6 jnol dm-3 + Cu(II) 4.76 x 10-6 + H2 O2  9.3 x 10-6 mol dm-3
iii) Reaction between cysteine and SNP
cysteine 1 x 10-3 mol dm-3 + g ^ P  1.25 x 10-3 mol dm-3
iv) Reaction between cysteine and RBS
cysteine 1 x 10-3 mol dm-3 + R gg 1.25 x 10-3 mol dm-3
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5.4 Discussion
Roussin's Black Salt (RBS) was a potent bactericidal agent towards E. coli killing 
50% of colonies at 4 x 1 0 - 6  mol dm"3. This toxicity increased with contact time and 
vai'ied with concenti'ation when tested in both light and darkness (appendix 1). Hughes 
e t a l } ^  by examining RBS [Fe4 S 3 (NO)7 ], sodium nitroprusside (SNP) [Fe(CN)5 NO] 
and the corresponding chromium species [Cr(CN)gNO] have shown that neither iron 
nor sulphur are essential for the bacteriostatic effects of Roussin’s type compounds. 
The property these compounds have in common is that they contain NO+. It is 
proposed that NO"  ^is the active species and a relationship may exist between the N-O 
stretching frequency (a measure of the N 0+  character) and the toxicity of these 
compounds. The compounds RBS and SNP donate the species N 0+ which has a N -0  
stretching frequency of 2300 cm 'k  RBS was 400 times and SNP 20 times more toxic 
towards E. coli than SNAP and GSNO, which donate NO and have a lower N-O 
stretching frequency of 1840 cm k
SNP was toxic towards E. coli in darkness with 50% of colonies killed at 1 x 10-3 mol 
dm-3. Following exposure to light this concentration was not toxic (appendix 1). RBS 
and SNP are good nitrosating agents towards a variety of substrates including amines, 
ca rt anions and thiols.
Peroxynitrite was a potent bactericidal agent killing E. coli in direct proportion to its 
concentration with 50% of colonies killed at 1.5 x 10-"^  mol dm-3. This toxicity 
increased with contact time (appendix 1). RBS, SNP and peroxynitrite were more 
tox ic  tow ards E. co li than  the S -n itro so th io ls  SN A P and G SN O . 
Dibenzylhydroxyguanidine (DBHG) was the least toxic of the compounds tested with a 
concentration of 5 x 10-2 mol dm-3 required to kill 50% of colonies (appendix 1).
The greater effect of RBS, SNP and peroxynitrite may be due more to the transfer of 
the coordinated nitrosyl group to cellulai' tar gets than to the release of nitric oxide. This
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is borne out by the fact that NO is less toxic to C. sporogenes than iron nitrosyl 
complexes
The site of action of the toxic species is thought to be the cell membrane. Payne et al?-^ 
showed by election microscopy that cells treated with RBS at lethal concentrations 
caused the apparent optical density to decrease, indicating cell lysis. Potential targets 
under investigation include the cell membrane and the cell wall components. It is to be 
expected that there will be variation in effectiveness resulting from differences in 
aqueous solubility, stability in the medium, charge and liposolubility. In order to 
maximise contact between the test compound and cell membrane the cell wall was 
disrupted using ampicillin and lysozyme. This process increased toxicity slightly for all 
the compounds tested with the exception of peroxynitrite (appendix 2). The toxic 
species in the case of peroxynitrite may require the cell wall to be present in order to 
function optimally.
Because activated macrophages simultaneously synthesise superoxide and nitric oxide, 
their reaction product peroxynitrite is thought to be a transient bactericidal agent 
produced by these cells. The reaction of superoxide with nitric oxide is rapid with a 
rate constant of at least 3.7 x 10^ m"l s“l
O NOO'
Peroxynitrite is a strong oxidant capable of reacting by multiple oxidative mechanisms. 
The peroxynitrite anion directly oxidises sulphydryl groups at a rate a thousand times 
faster than hydrogen peroxide. The anion also reacts with metal ions and with 
superoxide dismutase to form a potent nitrating agent with reactivity of the nitronium 
ion. Furthermore, peroxynitrite has a pKa of 6 . 8  so that 20% will be protonated at 
physiological pH.
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_  NO,- + HO
ONOO’ + H* — — ONOOH
NO3 + H+
It has been proposed that peroxynitrous acid (ONOOH) spontaneously decomposes to 
form a potent oxidant with the reactivity of a hydroxyl radical without a requirement for 
transition metal catalysis. 1 2  it is interesting that while many studies of the nitric 
oxide/superoxide interaction demonstrate augmented cytotoxicity,24 others show 
diminished cytotoxicity .26
Zhu et a/. 13 found that peroxynitrite was highly bactericidal killing E. coli in direct 
proportion to its concentration. Metal chelators did not decrease peroxynitrite mediated 
Idlling, indicating that exogenous transition metals were not required for toxicity. The 
hydroxyl radical scavengers mannitol, ethanol and benzoate did not significantly affect 
toxicity while dimethyl sulphoxide (DMSO) enhanced peroxynitrite mediated killing. 
DMSO is a more efficient hydroxyl radical scavenger than the other tlnee and increased 
the formation of NO%. The formation of NO 2  may have enhanced the toxicity of 
peroxynitrite decomposing in the presence of DMSO.
Our studies further confirmed that the hydroxyl radical produced by the decomposition 
of peroxynitrite did not account for the observed toxicity towards E. coli. L-ascorbic 
acid (a scavenger of HO ) did not significantly decrease the toxicity of peroxynitrite. 
However, evidence for hydroxyl radical production was presented by ESR (appendix 
3). These results indicate that another species produced by peroxynitrite must be 
responsible for the observed toxicity. Talcing into account that peroxynitrite was highly 
toxic towards E. coli, with comparable toxicity to NO+ donor compounds (RBS, SNP) 
it is not unreasonable to postulate that N 0+ produced by peroxynitrite decomposition is 
the toxic species.
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ONOOH ------------^  NO"^  + HOO
SNAP decomposes to form the corresponding disulphide and NO. The effect of 
copper (II) ions on its decom position and hence toxicity towards E. coli was 
investigated. It was demonstrated that copper in the form of Cu(II) acetate enhanced 
the decomposition of SNAP and hence the production of NO resulting in increased 
toxicity. However at concentrations greater than 5 x 10'3 mol dm-3 Cu(II) acetate was 
toxic (appendix 4).
An attempt was made to produce a mutant strain of E. coli using the mutagen 1,2,7,8- 
diepoxy octane. Ideally the strain produced would be resistant to RBS and therefore 
allow investigation of the toxicity mechanisms of test compounds in comparison to 
RBS. However, the production of a RBS resistant strain was unsuccessful, partly due 
to the insolubility of RBS in agar-containing medium. However, the resultant strain 
was tested with RBS and SNAP and further confirmed the greater cytotoxicity of a 
N 0+ donor (RBS) in compaiison with a NO donor (SNAP).
Previous reseaich^^ demonstrated that nitroprusside crosses the eiythrocyte membrane. 
The apparently low transport rate of nitroprusside into red blood cells^^ determined by 
experiments with caihon-14 labelled nitroprusside can be rationalised by consideration 
of the toxic effects of nitroprusside on cells. It has been postulated that the greater 
toxicity of NO+ donor compounds (RBS, SNP) is attributed to increased membrane 
solubility. This theory was investigated using octanol to mimic the cell membrane and 
solubility was determined by spectrophotometry. SNAP and RBS were considerably 
more soluble in the organic (octanol) layer than in the aqueous layer. However, SNP, 
although soluble in the organic layer, was slightly more soluble in the aqueous layer 
(appendix 5). On the basis of these findings the ability to dissolve in the cell 
membrane alone does not explain the observed antibacterial effect.
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A nitric oxide sensor was used to follow the decomposition of SNAP catalysed by 
Cu(II) acetate (appendix 6 ), NO evolution was observed reaching a maximum after 22 
minutes. This reaction was repeated adding hydrogen peroxide, consequently the 
amount of NO produced was reduced by 50% and maximum evolution occurred after 
10 minutes. In the presence of hydrogen peroxide NO is oxidised to nitrite and nitrate 
and therefore accounts for the reduced evolution of NO from SNAP decomposition.
The reactions between cysteine/RBS and cysteine/SNP were also studied (appendix 6 ). 
Maximum NO evolution from cysteine/RBS was observed after 265 minutes, while 
maximum NO evolution from cysteine/SNP was observed after 340 minutes. These 
results suggest that in the presence of a thiol (cysteine), NO was not readily produced 
from either RBS or SNP. Kaplan et aZ.28 have shown that NO mediated killing of S. 
aureus was not manifested until about 5 hour exposure had occurred, thus providing 
further evidence that NO is not the species (or main species) responsible for the 
observed toxicity of RBS and SNP towards E. c o li .
From the evidence presented it appears that the toxicity of SNP, RBS and possibly 
peroxynitrite towards E. coli is due to the transfer of NO+ to cellular targets rather than 
to the release of NO.
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Appendices
i) Toxicity Studies
IC 5 0  values of test com pounds - the concentration at which 50% of colonies are 
killed relative to control.
co m p o u n d  concen tra tion  (m ol dm  3)
RBS 5.0 X 10-5
ONOO- 1.5 X 10-4
SNP 1.0 X 10-3
SNAP 2 .0  X 1 0 -2
GSNO 2.5 X 10-2
DBHG 5.0 X 10-2
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The toxicity of RBS: variation with contact time
■s
.2*SI
1.4x 10’4 mol dm"  ^
6.8x10"^ mol dm"  ^
2.8x10"^ mol dm"^
contact time (min)
The toxicity of peroxynitrite: variation with contact time
'S
$1■© B
Ii J
1.6x10"^ mol dm"  ^
1.6x10"^ mol dm“3
contact time (min)
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The Effect of Light on SNP Toxicity
125
1 0 0 -
^  75 -
J
I  5 0 -  w
25 -
ooo ooo
M light * 
■  dark
conc (mol dm"^)
* 200 Watt bulb at a distance of 30 cm
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Appendix 2
ii) D isru p tio n  o f the Cell W all of E. coli W ith  A m pic illin  (100 jiig/cm ^ 
c u ltu re )
compound conc (mol dm"^) % colonies killed % colonies killed 
(ampicillin)
ONOO 1.6 X 10-4 73 72
1 . 6  X 10-5 9 9
R B S 3.8 X 10-4 1 0 0 1 0 0
4.0 X 10-5 42 62
S N A P 1.8 X 10-2 53 62
4.5 X 10-5 4 13
G S N O 1.8 X 10-2 42 61
4.5 X 10-5 0 0
D isru p tio n
c u ltu re )
o f th e  Cell Wall of E, coli W ith  Lysozym e (100 |ig /c m
compound conc (mol dm'^) % colonies killed % colonies killed 
(lysozym e)
ONOO" 1 . 6  X 10-4 65 48
1.6 X 10-5 8 1
RBS 1.9 X 10-4 1 0 0 1 0 0
9.5 X 10-5 61 57
SNAP 1.1 X 10-2 35 48
8.5 X 10-5 1 2 16
G S N O 1 . 1  X 1 0 - 2 29 35
9.2 X 10-5 7 0
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Appendix 3
iii) The Effect of L-Ascorbic Acid on Peroxynitrite Toxicity
'S
peroxynitrite
peroxynitrite + L-ascorbic acid
conc (mol dm"^)
ESR Studies: Peroxynitrite
The following compound was detected: 
a ( l H )  1.4 G 
a(N)  160
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Appendix 4
iv) SNAP Decomposition, the Effect of Cu(II)
100
■2
75 -
5 0 -
25 -
% colonies killed
oo (S
U
+
U
+
SNAP conc (mol dm‘ )^
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D is tr ib u tio n  S tud ies
Appendix 5
com pound
SNAP
la y e r  X (nm )
RBS
SNAP
organic
aqueous
organic
aqueous
organic
aqueous
342.7
339.2 
351.0
353.8 
199.7
192.3
Abs (A)
1.750
0.404
1.634
0.703
2.196
2.996
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Appendix 6 
Reactions monitored using a NO sensor
i) T he decom position o f SNAP by C n(II)
SNAP 9.1 X 10"6 mol dm"^ + Cu(H) 4.76 x 10"^ mol dm"^
0 .5 -
ooo >n
[NO] \im
tim e (min)
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ii) T he decom position of SNAP by C n(II)
" th e  effect o f hydrogen  peroxide
SNAP 9.1 X 10"^ mol dm"^ 4- Cu(II) 4.76 x 10"^ mol dm“^  
+ H2 O2  9.3 X  10-6 mot dm-3
0.6
0 .5 -
0.4 -
3.
0 .3 -©
0.2 -
0.1 -
o o m
[NO] |Lim
tim e (m in)
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îii) Reaction betweeen cysteine and
cysteine 1 x 10“^  mol dm“^  + SNP 1.25 x 10"^ mol dm“^
[NO] nm
tim e (min)
©
Iv) R eaction  betw een cysteine and MBS 
cysteine 1 x 10"^ mol dm“^  + RBS 1.25 x 10"^ mol dm“^
□ □
tim e (min) 
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□ [NO] nm
Chapter 6 
Leishmaniasis, a Model for Malaria?
6.1 Introduction
Leishmaniasis refers to a spectrum of diseases caused by parasitic protozoa belonging 
to the genus Leishmania. All forms of leishmaniasis begin with a bite from a sandfly 
vector. The amastigote form of the paiasite is ingested by the sandfly during a blood 
meal and develops into the promastigote foim  in the sandfly gut. The insect deposits 
the extracellular promastigote into mammalian skin. The parasite subsequently 
undergoes phagocytosis whereupon it converts to the amastigote form. Thus their 
means of entry into macrophages and their resistance to macrophage microbicidal 
mechanisms aie critical for the organism's subsequent survival.
Leishmania replicate only within macrophages of an infected host. Elimination of the 
parasite and resolution of disease must invoke extraordinary metabolic changes in the 
infected macrophage. These changes shift the intracellulai* environment of the parasite 
from one that is supportive of replication to one that is hostile to survival. Both in vitro 
and in vivo studies convincingly demonstrate that the intracellular persistence of L. 
major depends on the differentiate state of the macrophage at the onset of infection.
The intracellular conversion of the sandfly-adapted promastigote into the amastigote 
form is instrumental to the survival and propagation of the leishmania species. Unlikei
the promastigote of L. major the amastigote is quite resistant to the antimicrobial 
mechanisms of the unstimulated macrophage. For instance, attachment and entry of 
either the promastigote or the amastigote into macrophages elicits a superoxide 
synthesising respiratory burst which the amastigote readily survives. Unlike the 
promastigote, L. major amastigotes are also less sensitive to cytokine-induced, oxygen 
dependent antimicrobial mechanisms such as hydrogen peroxide. 1
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6.1.1 The Antiparasitic Nature of Nitric Oxide
The precise nature of the metabolic changes in the amastigote induced by nitrogen 
oxides that result in death of the parasite are unknown. Several effects of L-arginine 
catabolism in other systems, however, may shed light on the intracellular fate of the 
amastigote.
Iyengar et al?- speculated that N-guanido-hydroxylated arginine, a postulated 
intermediate in the conversion of L-arginine into NO and L-citrulline, is a potent 
inhibitor of DNA synthesis. In as much as N-hydroxylated guanidines possess 
antitumour and microbicidal activity, it is possible that such derivatives inhibit DNA 
synthesis and are the proximal cause of amastigote cytostasis in IFN-y treated 
macrophages.
The generation of NO by activated macrophages also induces the haem-dependent 
activation of guanylate cyclase with the subsequent stimulation of the secondary 
messenger cGMP, which may in turn serve as a signal for monokine production. 
Another possibility is that NO may be the actual effector molecule that causes stasis 
and/or lysis of the intracellular paiasite. This could explain intracellular iron loss and 
inhibition of enzymes with iron-sulphur prosthetic groups that are important in a 
number of metabolic pathways and in certain microorganisms.3 Cytotoxic activated 
macrophages inhibit two oxidoreductases of the mitochondrial electron transport chain 
in tumour targets,^ the citric acid cycle enzyme aconitase and DNA replication.^ Each 
of the enzymes have a catalytically active iron linked to a sulphur group that could be 
degraded by NO and released as an iron-nitrosyl complex. NO gas mimics 
macrophage-mediated tumour cytotoxicity, inliibition of mitochondrial aconitase activity 
and respiration. Leishmania infected macrophages may cause iron efflux, followed by 
Lon-dependent enzyme inhibition in the amastigote.<^
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6.1.2 The Effect of Qinghaosu and its Derivatives on Leishmania
The artemisinin family of compounds are characterised by having an endoperoxide 
bridge within the molecule. W hether the endoperoxide bridge is essential for 
antiieishmanial activity as it is for antimalaiial activity is unknown. Under in vivo 
conditions metabolism of the endoperoxide linkage of qinghaosu and its derivatives by 
parasites may generate oxygen radicals w hich are detrim ental to parasite 
macromolecules.
The effect of qinghaosu and its ether derivative artemether on L. major replication in 
vitro  and on the disease development in mice infected with L. major have been 
investiga ted .7 BALB/c mice infected in the footpad with L. m ajor d eveloped  
significantly smaller lesions and parasite loads when treated with these compounds. 
Intra-lesion injection was the most effective route, intramuscular and oral routes were 
also effective, but to a lesser extent.
Qinghaosu and its derivatives have been shown to be effective against Schistosoma  
mansoni  ^ and Clonorchis sinensis!^ Therefore, this group of compounds may have 
broad antiparasitic potential. These compounds have no effect on the viability of 
macrophages and the activity of lymphocytes to proliferate in vitro. Given this low 
toxicity in vitro, their reported safety profile in vivo and their effectiveness when 
administered orally, this series of compounds are potentially useful therapeutic agents 
in the treatment of clinical leishmaniasis.
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6.2 The Effect of Flavonoids on the Antimalarial Activity of 
Qinghaosu
Most natural antioxidants aie from plants. The most common are flavonoids (flavanol, 
isoflavones, flavones, catchins and flavanones). Natiual antioxidants may function as 
reducing agents, free radical scavengers, as complexes of pro-oxidant metals and as 
quenchers of the formation of singlet oxygen. Many flavones are present in the 
Chinese herb At'temisia annua . For centuries malaria has been treated with a decoction 
from a combination of herbs including A. annua. These herbs were boiled in water and 
strained before drinking. This decoction proved very effective. It appears that small 
amounts of qinghaosu in the plant aie more effective when unrefined. Therefore, it is 
possible that a synergistic effect occui's in herbal combinations.
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6.2.1 M a jo r F lavones of Artem isia annua  P lan ts  and  Cell C u ltu res
OH O
com parison  of levels of m a jo r 
flavones in  p la n t and  cu ltu res of A. annua
DW of plant % DW of suspension
a rte m e tin  R i=R 2 =R 3 =OCH 3  
c a s tic in  R i=R 3 =OCH 3 , R2 =OH 
chrysoplenetin  R i= R 2 =O CH 3 , R 3 =OH 
chrysoplenol-D  R i= O C H 3 , R 2 =R 3 =OH 
c irs i lin e o l Ri=H , R 2 =OCH 3 , R 3 =OH 
e u p a to r in  R p H , R 2 =OH, R 3 =OCH 3  
(DW= Diy Weight)
0 0.07
0 . 0 1 0
0.04 0.06
0 . 1 0 0.06
0 . 0 1 0.05
0 . 0 2 0
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Cell suspension cultures developed from A. annua exhibited antimalarial activity in 
vitro with P. falciparum  in both the n-hexane extiact of the plant cell culture medium 
and in the chloroform extract of the cells. Trace amounts of qinghaosu account for the 
activity of the n-hexane fraction but only the methoxylated flavones artemetin, 
chrysoplenetin, chrysoplenol-D and cirsilineol can account for the activity of the 
chloroform extract.
6.2.2 The Inhibition of [^H] Hypoxanthine into P. falciparum  in vitro 
by Extracts of Cell Suspension of A. annua
solvent extract in vitro antiplasmodial activity
I C 5 0  ( |lg /cm 3)
n-hexane (medium) 15.6
chloroform 14.5
methanol (cells) 500
Trace amounts of qinghaosu detected in the n-hexane fraction were responsible for 
inhibiting the incorporation of pH ] hypoxanthine, causing paiasite death. However, 
no qinghaosu was detected in the chloroform extract of the cells. This latter extract 
contained methoxylated flavonoids some of which aie known to be cytotoxic. 1 2
These purified flavones have IC 5 0  values at 2.4 - 6.5 x 10"^ mol dm"3 against P. 
fa lciparum  in vitro compared with an IC 5 Q value of 3 x 10'^ mol dm"^ for purified 
qinghaosu. At concentrations of 5 x 10'^ mol dm"^ these flavones were not active 
against P. falciparum  but did have a marked and selective potentiating effect on the 
antiplasmodial activity of q i n g h a o s u .  13
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6.2.3 T he In h ib ito ry  E ffect o f F lavones A lone o r w ith  Q inghaosu  
-incoiporatioii of [^H] hypoxanthine into P. falciparum  -
IC50
q in g h a o su
artem etin
c a s tic in
c h ry so p le n e tin
c h ry so sp le n o l-D
c irs ilin e o l
e u p a to r in
flavonoid alone 
(M x 10-5)
2.6
2.4
2.3
3.2 
3.6
6.5
qinghaosu (M x 1 0 ^) 
+ flavonoid (5 pM)
3.3
2.6
2.6
2.25
1.5
1.6
3.0
To some extent all the methoxylated flavonoids except eupatorin had a comparable 
potentiating effect on the in vitro antiplasmodial activity of qinghaosu. Since the 
flavones have little effect on the dose response cuive of chloroquine at concentrations 
which significantly enhance the antimalarial activity of qinghaosu, this suggests a 
different mechanism of action of these c o m p o u n d s .  13
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6.2.4 Structure-Related Activity^ ^
3'
t-
0
The flavones studied were all methoxylated at C - 6  and C-7; however, except for 
eupatorin where only slight potentiation of qinghaosu activity was observed, variations 
in methoxy 1-hydroxyl substitution at C-3, C-3' and C-4' appeared to have a limited 
effect on antimalaiial activity. This suggests that for potentiating activity, if there is no 
substitution at C-3 in eupatorin or cirsilineol, then unsubstituted oxygen at C-4' is 
required as in cirsilineol.
If  C-3 is substituted with a methoxyl the ring P may have either C-3', C-4' dihyroxyl 
(chrysoplenol-D); C-3' hydroxyl, C-4' methoxyl (casticin); C-3' methoxyl, C-4' 
hydroxyl (chrysoplenetin) or C-3', C-4' dimethoxyl (artemetin) for potentiating activity 
to be observed. Why eupatorin has so little effect was not clear from the results. 
Sufficient flavonoids have not been tested biologically in order to ascertain the 
structural requirement of flavonoids which potentiate the activity of qinghaosu towar ds 
P. falciparum. Furthermore, the activity of qinghaosu towards a number of parasites 
including leishmania may be enhanced when combined with flavonoids.
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6.3 Properties of Flavonoids
6.3.1 Antioxidant and Iron-Chelating Activities
Flavonoids have been reported to exert multiple biological effects, including antioxidant 
and free radical-scavenging a b i l i t ie s .T h e ir  anti-radical property is directed towards 
highly reactive species implicated in the initiation of lipid peroxidation. Flavonoids
are soluble chain-breaking inhibitors of the peroxidation process, scavenging 
intermediate peroxyl and alkoxyl r a d i c a l s .  1  ^ Phenolic compounds also have been 
suggested to present a strong affinity for iron ions^'^ which aie known to catalyse many 
processes leading to the formation of free radicals. Thus, the antiperoxidative 
capability of flavonoids may be due to concomitant activities of scavenging free radicals 
and chelating iron.
6.3.2 Flavonoids as Scavengers of Nitric Oxide (NO)
Flavonoids aie clinically used in diseases of the vascular wall involving inflammation 
and endothelial damage. Venomtin, a semi-synthetic hydroxyethylrutoside mixtrue is 
used to reduce capillaiy permeability in chronic venous insufficiency and to protect the 
endothelial layer of blood vessels in diabetes mellitus.l^ In endothelial damage and 
inflammation free radicals play a major role. Most radicals possess both beneficial as 
well as undesirable effects This holds especially true for NO. On one hand NO is a 
key mediator in various physiological processes and on the other NO is toxic e.g. as a 
precursor of peroxynitrite.^-l Studies have shown that flavonoids are excellent NO 
scavengers. Their activity exceeds that of glutathione 10 to 1000 times . 2 2
As mentioned previously NO has both beneficial as well as undesirable effects. NO is 
a m ediator of inflammation^^ and plays a role in the defence mechanism of 
macrophages against m i c r o - o r g a n i s m s .^ ^  ]s^o generated by inflammatoiy cells is toxic,
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probably after reaction with the superoxide anion which gives rise to peroxynitrite. 
Once protonated peroxynitrite may decompose to form the reactive HO and the stable 
NO 2  as suggested by Beckman et a l  ^5 Scavenging NO radicals contributes to the 
therapeutic effect of flavonoids.
In blood vessels NO is produced by endothelial cells, upon stim ulation of 
muscaiinergic receptors. The NO diffuses into the vascular smooth muscle where NO- 
induced cGMP formation leads to muscle relaxation. Scavenging of this NO leads to 
vasoconstriction and possibly vascular damage. Flavonoids appear to accumulate 
between the endothelial layer and the vascular smooth muscle cells where a high 
concentration is r e a c h e d . T h i s  would favour the scavenging of the endothelial 
derived NO which is responsible for vasodilation. However at the site where 
flavonoids accumulate arteriosclerosis begins in a process where undoubtedly NO 
radicals display an unfavourable role.
A correlation between the intake of flavonoids and a low incidence of car diovascular 
disease has been f o u n d . 2 7  Therefore, it is tempting to speculate that the NO 
scavenging properties of flavonoids play an important role in their therapeutic effect. If 
indeed NO is one of the major protective features of flavonoids, how does the 
scavenger discriminate between the wanted and deleterious NO? Probably the local 
distribution of the flavonoid has to be taken into consideration.
These findings demonstr ate the importance of flavonoids in many disease states and in 
the enhanced performance of qinghaosu towards the malarial parasite Plasmodium  
falciparum.
Leishmaniasis is often used as a model for malaria since malarial parasites {plasmodia) 
are extremely difficult to culture. By comparison with Plasmodia it is not unreasonable 
to expect enhanced activity of qinghaosu towards leishmania when combined with 
flavonoids.
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6.4 Research programme
The previous discussion highlights the importance of NO in microbicidal activity 
including death of the intracellular parasite. Consequently, the antiparasitic activity of 
the NO donor compounds SNP, SNAP, GSNO and RBS were tested in vitro w ith 
Leishmania mexicana amastigotes.
The artemisinin family of compounds are potent antimalarials which show broad 
antiparasitic potential. They have been tested in vivo and in vitro with Leishmania  
major 7 and were found to exhibit antiieishmanial activity. In this study qinghaosu, 
artemether and arteether were tested with L. mexicana amastigotes in vitro.
It has been shown^^ that many flavones are present in A. annua (the Chinese herb 
from which qinghaosu is extracted). Flavones are natural antioxidants, reducing 
agents, free radical scavengers (including NO) and are capable of chelating iron. They 
have been shown to potentiate the antimalarial activity of qinghaosu and therefore may 
enhance the activity of qinghaosu towards L. mexicana. In order to produce a range of 
m ethoxylated flavones the concept of combinatorial chem istry was employed. 
Combinatorial chemistry is a novel and innovative way of rapidly generating a number 
of related compounds. This idea has been adapted by the pharmaceutical industry over 
the last decade and has meant that a large number of compounds can be screened 
rapidly for biological activity
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Test Compounds
R oussin 's  B lack  S a lt (RBS)
ON NO
S odium  n itro p ru ss id e  (SNP)
S -n itro so -N -ace ty lp en ic illam in e  (SN A P)
W R ^ C -C -  CH
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S-nitrosoglutathione (GSNO)
CH
Q in g h ao su A rtem ether A rtee th e r
.CHCH.CH
J  CH 
O CH .CH
CHCH
OCH
Q u erce tin
OH
OH
HO.
OH
OH O
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Rutin
OH
OH
HO.
OH O
OH OH OH OH
A m ix tu re  of m e thy la ted  q u erce tin  p ro d u c ts  (some hydroxyl groups were 
replaced with methoxyl groups).
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6.5 Experimental 
Instrumentation and General Techniques
NMR specti'a were recorded on a Varian Gemini spectrometer operating at 200 MHz for 
iH  and 50.3 MHz for Mass spectra were generated on an A.E.I. M S-50
spectrometer. Plates were harvested using a Wallac Pharmacia 1295-004 Betaplate 96 
well harvester. In order to quantify the incorporation of radioactivity a W allac 
Phaimacia 1205 Betaplate liquid scintillation counter was used.
Test Compounds
RBS, SNAP and GSNO were prepared as described in chapter 5.
Qinghaosu, ar temether and arteether were gifts from the World Health Organisation. 
Quercetin and Rutin were purchased from Sigma and SNP from BDH.
Preparation of Methylated Quercetin p r o d u c ts ^  ^
Quercetin (2.03 g; 6  mmol) in acetone (9 cm^) and pulverised sodium hydroxide (3.84 
g; 0.1 mol) were warmed to 45°C with stirring, dimethyl sulphate (5.1 g; 0.04 mol) 
was added dropwise. This solution was warmed to 50“C for 90 minutes then 55-60“C 
for 3h. The solution was diluted with water and extracted with dichloromethane (3 x 
18 cm^), washed with water, 1 M hydrochloric acid and saturated sodium bicarbonate 
solution. The organic layer was dried over magnesium sulphate and the solvent 
removed under vacuum. The product was recrystallised from ethanol. Analysis 
confirmed, that upon méthylation quercetin decomposed to form a mixtiu*e of products. 
At this stage no attempt was made to sepaiate or characterise these products as the 
concept of combinatorial chemistry was being investigated.
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Preparation of Culture Medium
Culture medium was prepared using Schneiders drosophila medium (SDM); Gibco 
BRL lot 28F5745, foetal calf serum (FCS); Labtech 206 and gentamicin sulphate.
In order to prepare media (200 cm^); SDM (160 cm^) was combined with FCS (40 
cm^) and gentamicin sulphate (25 p.g/cm^). The pH of the resultant solution was 
adjusted to 5.5 with 1 M hydrochloric acid.
Preparation of Amastigotes for Culture from a Lesion
A BALB/c mouse infected with Leishmania mexicana was killed by breaking its neck. 
It was placed in a rubber glove filled with 70% ethanol and soaked thoroughly. The 
lesion was dissected, cut into small pieces and pushed through a wire gauze into 
medium (10 cm^). This suspension was taken up through a 19G needle into a syringe 
and pushed out through a 26G^/g needle to break open the mouse cells. The 
preparation was centrifuged at 1600g for 5 minutes, the supernatant was discarded and 
the pellet resuspended in medium (5 cm^). The amastigotes were counted using a 
haemocytometer and resuspended to a concentration of 4 x 10^ mol dm-3 per cm^ 
medium.
Preparation of Test Compounds
The compounds to be tested were prepared at 2 x 10"^ mol dm'^ or at 7 x 10“^  mol dm'^ 
in medium and filter sterilised before being plated in 96 well flat-bottomed microculture 
plates and supplemented with medium. The amastigotes were resuspended to 4 x 1 0  ^
mol dm‘3 per cm^ medium and pulsed with 1 pCi/well [^H] thymidine then plated. 
Plates were incubated in tiiplicate at 33°C and hai vested after 24 h. The incorporation
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of radioactivity was determined using a p scintillation counter. The results were 
expressed as counts per minute (cpm).
Determination of the Antiieishmanial Activity of NO Donor Compounds
The test compounds SNP, SNAP and GSNO were prepared at a concentration of 1 x 
1 0 " 2  mol dm’3 in medium and plated as previously described in "preparation of test 
compounds".
Determination of the Antiieishmanial Activity of Qinghaosu and 
Derivatives
Qinghaosu, artemether and arteether were prepared at a concentration of 1 x 10"^ mol 
dm'3 in medium and plated as previously described.
The Antiieishmanial Activity of Qinghaosu and Derivatives
In a control experiment the test compounds qinghaosu, quercetin, rutin and a mixture of 
methylated products were prepared at a concentration of 7 x 10‘4 mol dm’  ^ and plated 
as previously described.
The Effect of Flavones on the Antiieishmanial Activity of Qinghaosu
Each of the compounds to be tested ; quercetin, rutin and methylated quercetin products 
were prepared at a concentration of 7 x 10'4 mol dnr^ and plated with qinghaosu also 
prepared at 7 x 10'4 mol dnr^ in medium.
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6.6 Discussion
There has been much interest in the biological role of NO as a widespread transduction 
mechanism leading to a variety of functions in different cells. Activated macrophages 
form nitrite and nitr ate from the terminal guanidino nitrogen atoms of L-ar ginine by a 
process Imown to proceed by via the formation of NO. This pathway is responsible for 
the cytotoxic action of macrophages, NO may disrupt iron-dependent enzymatic 
pathways vital to the survival of amastigotes in macrophages. Antiieishmanial activity 
was suppressed in a dose dependent fashion by L-NMMA (a competitive inhibitor of 
NO from L-arginine). Excess L-arginine added to infected macrophage cultures 
reversed the inhibitory effects of L-NMMA.^
Of the NO donor compounds tested with L. mexicana amastigotes; RBS was insoluble 
in SDM (the medium crucial for parasite survival). Attempts were made to solubilise 
RBS in ethanol and in dimethyl sulphoxide (DMSO) and then supplement these 
solutions with SDM. However, in each case addition of medium caused RBS to come 
out of solution. Each solution (RBS in; SDM, DMSO/SDM and ethanol/SDM) was 
filtered and tested, but exhibited no toxicity towards L  mexicana, in contrast with the 
high toxicity of RBS observed with E. coli (chapter 5). It is likely that insufficient 
RBS dissolved in order to reproduce the toxicity previously observed.
SNP was more toxic than SNAP and GSNO at concentrations lower than 3.70 x 10“^  
mol dm’3. At higher concentrations (1 x IQ-^ - 3 x 10'^ mol dm"^) antiieishmanial 
activity was compar able (appendix 1 ).
The greater toxicity exhibited by SNP at lower concentrations could be due to the 
transfer of NO+ to cellular targets rather than to the release of NO.30 The S- 
nitrosothiols SNAP and GSNO are NO donors and were less toxic than SNP towards
E. coli (chapter 5). Previous research found that a saturated solution of NO did not 
inhibit parasite growth.31
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Nitric oxide can react rapidly with superoxide to generate the peroxynitrite anion which 
is a more powerful oxidant than NO.25 Peroxynitrite can decompose yielding hydroxyl 
radicals and it has been proposed that these radicals may be involved in tissue damage 
and killing attributable to NO. Assreiiy et aZ.32 have shown that authentic peroxynitrite 
failed to induce any cytotoxic effect towards L. major even at a high concentr ation.
Yang et alP  studied the effect of qinghaosu on L. major promastigotes in vitro and 
found that the parasites decreased progressively with increasing concentrations of 
qinghaosu and no viable parasites were detected at around 10-5 mol dm-3 by 
radioactivity incorporation. In addition, qinghaosu and artemether were capable of 
killing intracellular* parasites with IC 5 0  values of 3 x 10“5 and 3 x 10-^ mol dm-3 
respectively.
The results show that at concentrations of 3.70 x 10'4 mol dm“3 and higher, arteether 
was approximately 50% more effective at killing L. Mexicana amastigotes than 
qinghaosu and artemether in vitro (appendix 2). The artemisinin family of compounds 
are characterised by having an endoperoxide bridge within the molecules. Whether the 
endoperoxide bridge is essential for their antiieishmanial activity as it is for antimalarial 
activity is at present unclear. However, under in vivo conditions, metabolism of the 
endoperoxide linkage of qinghaosu and its derivatives may generate oxygen radicals 
which ar e detrimental to parasite macromolecules.
In contrast with the antiieishmanial activity of NO donor compounds (appendix 1), 
qinghaosu and its derivatives were significantly less toxic towards L. mexicana  
amastigotes at concentrations greater than 3.70x10-^ mol dm-3, indicating the superior 
toxicity of NO/NO+ in comparison with metabolised qinghaosu species.
Previous work demonstrated the potentiating effect of methoxylated flavones on the 
antimalarial activity of q i n g h a o s u . 3^ it was considered that this potentiating activity 
may apply to a range of par asites including leishmania. Thus, methoxylated flavones 
may also potentiate the antiieishmanial activity of qinghaosu.
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The antiieishmanial activity of qinghaosu was compared with the activity of flavones; 
rutin, quercetin and a mixture of methoxylated flavones. The activity of qinghaosu was 
consistent with the previous study (appendix 2 ) with the percentage initial [^H] 
thym idine uptake 36.5% at 7.09 x 10'"^ mol dm-3. Quercetin was tested at 
concentrations 7.09 x 10-^ - 8.75 x 10'^ mol dm-3 and show ed negligible 
antiieishmanial activity. Rutin, tested at concentrations 7.0 x 1 0 "  ^- 8.64 x lO'^ mol 
dm-3 also had negligible antiieishmanial activity. However, the mixture of methylated 
quercetins was toxic and killed L. mexicana amastigotes with IC 5 0  between 7.78 x 10-5 
- 2.59 X 10-5 uiol dm-3 (appendix 3).
Qinghaosu was combined with each of the flavones mentioned previously in order to 
observe the effect on antiieishmanial activity. Rutin and the mixture of methylated 
quercetin products were prepared at concentrations 1.75 x 10-^ - 5.47 x 10-^ mol dm-3 
and plated with qinghaosu 1.75 x 1 0 - 4 -  2.75 x 10-^ mol dm-3. Quercetin was prepared 
at 1.77 X 10-4 -  5 . 5 3  X 10"^ mol dm-3 and plated with qinghaosu as above. However, 
no potentiating effect was observed for any flavone, even although the mixture of 
methylated quercetin products tested in the absence of qinghaosu was toxic towards L. 
mexicana. This advantage was completely lost upon combination with qinghaosu and 
only slight antiieishmanial activity was observed. This activity was comparable to that 
exhibited by qinghaosu alone.
Methoxylated flavones have been shown to exliibit antimalarial activity 13 and to some 
extent antiieishmanial activity (appendix 3). However, upon combination with 
qinghaosu they are selective in potentiating the antimalarial activity of qinghaosu.
The results obtained may be explained by iron complexation. Qinghaosu and flavones 
complex iron. Iron is essential for the antimalarial activity of qinghaosu and there are 
many examples in the literature of iron chelators which exhibit antimalarial activity. 
Hershko et al.'^^ explored the antimalarial effects of 3-hydroxypyridin-4-ones, a family 
of bidentate orally effective iron chelators and the iron chelator desferrioxamine (DFO)
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in vivo and in vitro. DFO is the standard iron chelator in clinical use, it is a naturally 
occuning trihydroxamic acid derived from cultures of Streptomyces pilosus.
All 3-hydroxypyridin-4-ones were found to be more effective than DFO, which was 
relatively ineffective as an intraerythrocytic non chelator. Hence, depriving the parasite 
of a metabolically important source of iron may represent a novel approach to 
antimalaiial di*ug development.
Morel et investigated the iron chelating ability of three flavonoids; catechin, 
quercetin and diosmetin using iron loaded rat hepatocyte cultures. They classified iron 
chelating ability as follows;
catechin > quercetin > diosmetin (which was quite devoid of effect)
OH
OH
HO.
OH
OH
catechin
HO
HO O .
OH O 
diosm etin
Cr“
OH
OH
OH O 
quercetin
OCH 3
DFO which was used as a reference remained the most effective agent.
173
The test compounds were poor iron chelators, with diosmetin (the methoxylated 
compound) being least effective. Therefore, the synergistic antimalaiial effect observed 
when qinghaosu was combined with methoxylated flavones may be due to factors other 
than increased iron chelation.
All experiments using L. mexicana parasites were performed in an iron rich medium, 
which is crucial for parasite viability. When the flavones quercetin and rutin were 
tested with L. mexicana paiasites no significant toxicity was observed. However, this 
was not the case for the mixture of methylated quercetin products which proved to be 
very toxic indeed. If  iron chelation is a measure of toxicity then the results obtained 
conflict with those of Morel et al 34 whereby the methoxylated flavone (diosmetin) was 
a poor iron chelator. Therefore, the observed toxicity may be due to a mechanism 
distinct from non chelation.
W hen qinghaosu was combined with the mixture of methylated quercetin products the 
previously observed toxicity was lost. Qinghaosu may complex iron, reducing the 
amount available to sustain parasite viability. In addition, the reaction between 
qinghaosu and iron results in the production of destructive free radicals which may 
cause parasite death. Both processes may account for antiieishmanial activity. 
However, it is possible that these processes occur sim ultaneously and the 
antiieishmanial activity observed is less than that of each process occurring singularly. 
In effect, negative synergism may explain our observations. Alternatively iron may be 
displaced by another metal, thus increasing its availability to sustain parasite viability, 
and consequently poor antiieishmanial activity results.
In conclusion, it has been shown that qinghaosu (alone or combined with flavones) had 
no significant effect on Leishmania mexicana amastigotes in vitro, and consequently for 
the requirements of this study leishmaniasis proved to be a poor model for malaiia.
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Appendices
Appendix 1
The Leishmaniddal Activity of SNP, SNAP and GSNO
II
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Appendix 2
T he L e ish m an id d a l A ctivity of Q inghaosu, A rtem eth er a n d  A rtee th e r
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Appendix 3
The Leishmaniddal Activity of Qinghaosu; a Comparison with Flavones
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